resultID,studyName,riskFactorName,fatality,fatalityLowerBound,fatalityUpperBound,fatalitypValue,fatalitySignificance,fatalityAdjusted,fatalityCalculated
1dd9e87d526f,"30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study","Smoking Status","OR 1.37",0.7,2.67,0.36,"Not Significant","Not Adjusted",Calculated
29f84466ac27,"30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study","Male gender","OR 2.24",1.02,4.91,0.04,Significant,"Not Adjusted",Calculated
9faafec2282f,"30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study","Overweight or obese","OR 2.38",1.11,5.1,0.03,Significant,"Not Adjusted",Calculated
062a7a1e8ade,"A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.",Hypertension,HR=1.28,0.99,1.67,0.06,"Not Significant","Not Adjusted",Extracted
526af45b432f,"A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.","Male gender",HR=1.59,1.23,2.06,<0.05,Significant,"Not Adjusted",Extracted
a382f078c5cc,"A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.","Chronic respiratory diseases",HR=1.37,1.03,1.84,<0.05,Significant,"Not Adjusted",Extracted
c81105bd30bd,"A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.","Chronic kidney disease",HR=1.34,1.0,1.79,0.05,"Not Significant","Not Adjusted",Extracted
ef5a06a88a0e,"A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.",Diabetes,HR=1.24,0.95,1.6,0.11,"Not Significant","Not Adjusted",Extracted
02ba5eb5cc87,"A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China",Age,,,,,,,
b64c2295eda1,"A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis Q1 patients with SARS-CoV-2 infection",Diabetes,"OR 1.7",0.69,4.2,0.25,"Not Significant","Not Adjusted",Extracted
f7955670a463,"ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan China","Chronic liver disease",,,,,,,
463de5a3c185,"Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis","Smoking Status",,,,,,,
8b5100a549fe,"Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)","Smoking Status",,,,,,,
3bc749cced6e,"Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence",Diabetes,AHR=2.84,1.01,8.01,,Significant,Adjusted,Extracted
4c686abbc3ce,"Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence",Cancer,AHR=0.82,0.18,3.65,,"Not Significant",Adjusted,Extracted
4cbfb081a198,"Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence",Hypertension,,,,,,,
6414fcc919df,"Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence",COPD,AHR=0.39,0.04,3.68,,"Not Significant",Adjusted,Extracted
7be3541d1d21,"Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence","Heart Disease",AHR=1.40,0.65,3.03,,"Not Significant",Adjusted,Extracted
c7988518f7bf,"Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence","Cerebrovascular disease",AHR=1.71,0.71,4.09,,"Not Significant",Adjusted,Extracted
32161e330f66,"Anakinra for severe forms of COVID-19: a cohort study","Male gender",,,,,,,
7c4be316c13d,"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes","Ethnicity_ Hispanic vs","OR 0.52",0.83,0.0,,Significant,"Not Adjusted",Calculated
802a04fc5738,"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes","Race_ Black vs","OR 0.63",1.0,0.05,,"Not Significant","Not Adjusted",Calculated
8cdfc7a016aa,"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes",Hypertension,"OR 1.42",1.99,0.0,,Significant,"Not Adjusted",Calculated
a0a9b26cd0be,"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes","Overweight or obese","OR 0.68",1.26,0.63,,"Not Significant","Not Adjusted",Calculated
a13b870cdbed,"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes","Smoking Status","OR 1.25",1.85,0.0,,Significant,"Not Adjusted",Calculated
a7b6c9457e44,"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes",Cancer,"OR 0.93",1.7,0.14,,"Not Significant","Not Adjusted",Calculated
ca6ac61eb323,"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes",Diabetes,"OR 1.19",1.72,0.0,,Significant,"Not Adjusted",Calculated
ed5f995e03ce,"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes","Male gender","OR 0.98",1.36,0.09,,"Not Significant","Not Adjusted",Calculated
6e627f1c1448,"Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19",Age,,,,,,,
cb7493537268,"Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19",Age,,,,,,,
8ea642752aca,"Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts","Heart Disease","OR 1.15",0.41,3.23,0.79,"Not Significant","Not Adjusted",Calculated
adeadbf175ee,"Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts","Male gender","OR 0.50",0.19,1.33,0.17,"Not Significant","Not Adjusted",Calculated
0c21545389ca,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19",Hypertension,,,,,,,
1ccfa5bf0fa7,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19","Heart Disease",,,,,,,
2c91cfcc9ca4,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19","Male gender",,,,,,,
33dcac4e992f,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19",Age,,,,,,,
37a4c6945451,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19","Heart Disease",,,,,,,
63d181c7c402,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19","Heart Disease",,,,,,,
82953e23e3bb,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19","Male gender",,,,,,,
c0fa3f8000b5,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19",Age,,,,,,,
c631f45e8aec,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19",Age,,,,,,,
de12de4b1c05,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19","Male gender",,,,,,,
e6875c2b3e44,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19",Age,,,,,,,
ee06e150bc0a,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19","Heart Disease",,,,,,,
eef507832c15,"Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19","Male gender",,,,,,,
04a53632f7b1,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Chronic respiratory diseases",AHR=1.06,0.8,1.4,,"Not Signficant",Adjusted,Extracted
06358bc98877,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences",Diabetes,AHR=1.35,1.13,1.62,,Significant,Adjusted,Extracted
09ebf940f729,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Cerebrovascular disease",AHR=1.95,1.64,2.31,,Significant,Adjusted,Extracted
157c8da36124,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Chronic kidney disease",AHR=3.25,2.29,4.63,,Significant,Adjusted,Extracted
1c550511ea93,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences",Diabetes,AHR=1.65,1.37,1.97,,Significant,Adjusted,Extracted
358f4680cd2b,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Cerebrovascular disease",HR=5.08,4.29,6.02,,Significant,"Not Adjusted",Extracted
49fb2155dc6d,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Cerebrovascular disease",AHR=1.98,1.67,2.36,,Significant,Adjusted,Extracted
52b199b12a8e,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Chronic respiratory diseases",AHR=1.26,0.95,1.67,,"Not Signficant",Adjusted,Extracted
5fab71bd1f8f,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences",Hypertension,AHR=1.67,1.46,1.92,,Significant,Adjusted,Extracted
658264cd04d2,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Chronic kidney disease",AHR=3.23,2.27,4.6,,Significant,Adjusted,Extracted
6cfde535a51e,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences",Hypertension,AHR=1.55,1.35,1.78,,Significant,Adjusted,Extracted
7d0b200513ff,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences",Hypertension,HR=3.74,3.27,4.28,,Significant,"Not Adjusted",Extracted
7edf13c0ef3c,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences",Hypertension,AHR=1.7,1.48,1.95,,Significant,Adjusted,Extracted
809ea1c49c20,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Chronic respiratory diseases",HR=2.5,1.89,3.3,,Significant,"Not Adjusted",Extracted
b3eb06e0dfc6,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Chronic kidney disease",HR=5.05,3.55,7.18,,Significant,"Not Adjusted",Extracted
b5bcff50cdf7,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences",Diabetes,HR=3.25,2.71,3.89,,Significant,"Not Adjusted",Extracted
b6e1586790cd,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Chronic respiratory diseases",AHR=1.33,1.01,1.75,,Significant,Adjusted,Extracted
bded69a0a2c5,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Cerebrovascular disease",AHR=1.7,1.43,2.02,,Significant,Adjusted,Extracted
d27f2bc71af8,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences","Chronic kidney disease",AHR=2.09,1.47,2.98,,Significant,"Not Adjusted",Extracted
e6b7457613e0,"Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences",Diabetes,AHR=1.66,1.39,1.99,,Significant,Adjusted,Extracted
43296d2af232,"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up","Chronic respiratory diseases","OR 1.28",0.43,3.79,0.44,"Not Significant",Adjusted,Extracted
66040e9ec111,"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up","Male gender","OR 1.16",0.74,1.81,0.51,"Not Significant",Adjusted,Extracted
788b27b7b948,"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up","Heart Disease","OR 1.57",0.86,2.87,0.19,"Not Significant",Adjusted,Extracted
7f8bccbb5513,"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up",Diabetes,"OR 1.39",0.73,2.64,0.29,"Not Significant",Adjusted,Extracted
95386ec528e8,"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up",Hypertension,"OR 0.99",0.44,2.2,0.99,"Not Significant",Adjusted,Extracted
f3f80b112a6d,"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up","Immune system disorders","OR 4.3",1.11,17.23,0.04,Significant,Adjusted,Extracted
231cba103266,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases",Hypertension,OR=3.16,2.51,3.97,<0.05,Significant,"Not Adjusted",Extracted
414ef6c2193b,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases",Diabetes,OR=2.45,1.82,3.3,<0.05,Significant,"Not Adjusted",Extracted
494326e8eb94,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases","Heart Disease",OR=4.67,3.22,6.77,<0.05,Significant,"Not Adjusted",Extracted
594ed5f61008,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases","Chronic liver disease",OR=2.81,1.31,6.01,<0.05,Significant,"Not Adjusted",Extracted
6639db10b2fe,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases","Chronic digestive disorders",OR=1.43,0.52,3.98,0.5,"Not Significant","Not Adjusted",Extracted
6bb94866a4e5,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases","Chronic respiratory diseases",OR=2.68,1.75,4.09,<0.05,Significant,"Not Adjusted",Extracted
6e0eff93810d,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases","Male gender",OR=2.26,1.79,2.86,<0.05,Significant,"Not Adjusted",Extracted
84dcce6dcdbe,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases","Cerebrovascular disease",OR=5.84,3.63,9.39,<0.05,Significant,"Not Adjusted",Extracted
991dd7e2ef0f,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases",Cancer,OR=2.16,1.41,3.33,<0.05,Significant,"Not Adjusted",Extracted
c888f51cf959,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases","Chronic kidney disease",OR=5.62,3.34,9.46,<0.05,Significant,"Not Adjusted",Extracted
9a190b409ac8,"Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis","Heart Disease","OR 11.08",2.59,47.32,,Significant,"Not Adjusted",Extracted
5f220582ef81,"Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study",Diabetes,AHR=2.80,1.01,7.8,<0.05,Significant,Adjusted,Extracted
f90c3a946bcd,"Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection",Diabetes,,,,,,,
ff5d11496559,"Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection",Hypertension,,,,,,,
2f786b6ad440,"Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis",Hypertension,OR=3.48,1.72,7.08,,Significant,"Not Adjusted",Extracted
0369b9a9374b,"Association of Obesity with Disease Severity among Patients with COVIDâ€19",Diabetes,,,,,,,
0ce704217100,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
0d6acf19c23a,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
0d9406bc02f2,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Race_ Black vs",,,,,,,
0da2741dd65c,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Chronic respiratory diseases",,,,,,,
1c3314fc5911,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Ethnicity_ Hispanic vs",,,,,,,
1d71312fddd6,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Heart Disease",,,,,,,
4325edd80299,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Race_ Black vs",,,,,,,
477ebf6be748,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
4af7efc0bdc2,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Smoking Status",,,,,,,
4c3fb04ec8f7,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
4f67c7a037e7,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Male gender",,,,,,,
6340233e1fd6,"Association of Obesity with Disease Severity among Patients with COVIDâ€19",Diabetes,,,,,,,
688bf01a7992,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
68f6b939c548,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Male gender",,,,,,,
77d03bbdbbd0,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
7d84ce02d4f1,"Association of Obesity with Disease Severity among Patients with COVIDâ€19",Hypertension,,,,,,,
8496f21dd177,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Ethnicity_ Hispanic vs",,,,,,,
8e32c133f315,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Male gender",,,,,,,
a5f92d7c93f5,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Heart Disease",,,,,,,
ade3cf5097bd,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Race_ Black vs",,,,,,,
b6972fb0157e,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
b70125496f3b,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Chronic respiratory diseases",,,,,,,
d217eda0ad5a,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
dc976c8c9aef,"Association of Obesity with Disease Severity among Patients with COVIDâ€19",Hypertension,,,,,,,
e7534262a14c,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Ethnicity_ Hispanic vs",,,,,,,
fdd77fd1932e,"Association of Obesity with Disease Severity among Patients with COVIDâ€19","Overweight or obese",,,,,,,
124601ed13ca,"Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19","Heart Disease",,,,,,,
223134739378,"Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19",Hypertension,,,,,,,
76d9474bd96f,"Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19","Male gender",,,,,,,
c27fc480be39,"Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19","Chronic kidney disease",,,,,,,
fee446a9bdee,"Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19",Diabetes,,,,,,,
3ef85d158a1d,"Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study [medrxiv]","Smoking Status",,,,,,,
67ea24d5cf98,"Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study [medrxiv]","Male gender",,,,,,,
20b56660e259,"Asthma prolongs intubation in COVID-19",Asthma,,,,,,,
73d8ac88577d,"Asthma prolongs intubation in COVID-19",Asthma,,,,,,,
c180e8c97966,"Asthma prolongs intubation in COVID-19",Asthma,OR=2.56,0.57,11.5,0.22,"Not Significant","Not Adjusted",Extracted
15fa712ac535,"Blood glucose is a representative of the clustered indicators of multi-organ injury for predicting mortality of COVID-19 in Wuhan China","Male gender",,,,,,,
d62178bf081d,"Blood glucose is a representative of the clustered indicators of multi-organ injury for predicting mortality of COVID-19 in Wuhan China","Male gender",,,,,,,
3d38828f20fd,"Cancer is associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis",Cancer,"OR 2.60",1.28,5.26,<0.01,Significant,"Not Adjusted",Extracted
d3cf20759362,"Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored","Male gender","OR 0.41",3.11,0.81,,"Not Significant","Not Adjusted",Calculated
13878cde67c9,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","Race_ Black vs","OR 0.53",1.1,0.15,,"Not Significant","Not Adjusted",Calculated
1df28a5e0593,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19",COPD,"OR 1.92",4.14,0.0,,Significant,"Not Adjusted",Calculated
5162822a9df7,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","Heart Disease",AOR=2.70,2.08,3.51,,Significant,Adjusted,Extracted
7a4064b1b7d2,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","Smoking Status",AOR=1.79,1.29,2.47,,Significant,Adjusted,Extracted
8e34560c5134,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19",COPD,AOR=2.96,2.0,4.4,,Significant,Adjusted,Extracted
942536478807,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","Heart Disease","OR 1.65",2.59,0.0,,Significant,"Not Adjusted",Calculated
a3cf0e097396,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19",Hypertension,"OR 0.77",1.16,0.56,,"Not Significant","Not Adjusted",Calculated
cdf2e81fa7c8,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","Smoking Status","OR 0.96",1.45,0.12,,"Not Significant","Not Adjusted",Calculated
f20a5e719a01,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","Ethnicity_ Hispanic vs","OR 0.63",1.33,0.64,,"Not Significant","Not Adjusted",Calculated
ff38090c6808,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19",Diabetes,"OR 1.13",1.79,0.0,,Significant,"Not Adjusted",Calculated
aadfecbaff98,"Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis","Heart Disease",OR=1.95,1.17,3.24,,Significant,"Not Adjusted",Extracted
dd371e83dfb2,"Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis","Heart Failure",OR=11.73,5.17,26.6,,Significant,"Not Adjusted",Extracted
3225b54bcf28,"Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis [medrxiv]","Heart Disease","OR 1.95",1.17,3.24,,Significant,"Not Adjusted",Extracted
dc26755edd5f,"Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis [medrxiv]","Male gender","OR 1.61",1.16,2.23,,Significant,"Not Adjusted",Extracted
4744307292ee,"Case fatality risk of novel coronavirus diseases 2019 in China",Age,"OR 1.18",1.14,1.22,<0.01,Significant,Adjusted,Extracted
82408f5f31c9,"Caution on Kidney Dysfunctions of COVID-19 Patients","Chronic digestive disorders",,,,,,,
8e5a8ef45e82,"Caution on Kidney Dysfunctions of COVID-19 Patients","Cardio- and cerebrovascular disease",,,,,,,
de348ccfc336,"Caution on Kidney Dysfunctions of COVID-19 Patients","Chronic respiratory diseases",,,,,,,
ed28a6ea7d4d,"Caution on Kidney Dysfunctions of COVID-19 Patients","Endocrine diseases",,,,,,,
0a4105e05338,"Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature","Cerebrovascular disease",OR=2.33,0.77,7.04,,"Not Significant","Not Adjusted",Extracted
155d550621e5,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Male gender",AHR=0.92,0.43,1.99,0.84,"Not Significant",Adjusted,Extracted
289ce79fea6c,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Male gender",AHR=0.78,0.33,1.86,0.57,"Not Significant",Adjusted,Extracted
2a24e7582511,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Chronic kidney disease",AHR=1.40,0.44,4.4,0.57,"Not Significant",Adjusted,Extracted
2d927f14536f,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Heart Disease",AHR=1.56,0.72,3.41,0.26,"Not Significant",Adjusted,Extracted
338ccce48187,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Cerebrovascular disease",AHR=0.35,0.08,1.58,0.17,"Not Significant",Adjusted,Extracted
34f450abfd13,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Chronic kidney disease",AHR=1.60,0.52,4.91,0.41,"Not Significant",Adjusted,Extracted
3c0a0abbd4cc,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019",Hypertension,AHR=1.07,0.46,2.53,0.87,"Not Significant",Adjusted,Extracted
538820f55f1e,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019",Hypertension,AHR=0.97,0.43,2.16,0.94,"Not Significant",Adjusted,Extracted
55f9000d93d3,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019",Age,AHR=1.04,1.0,1.07,<0.05,Significant,Adjusted,Extracted
5c5de1d24e73,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Heart Failure",AHR=1.75,0.52,5.91,0.37,"Not Significant",Adjusted,Extracted
7a27f92e84c1,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Heart Failure",AHR=2.42,0.83,7.06,0.11,"Not Significant",Adjusted,Extracted
83e2940fcfae,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019",Diabetes,AHR=1.16,0.47,2.85,0.75,"Not Significant",Adjusted,Extracted
8cbbe36553a4,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Heart Disease",AHR=1.63,0.61,4.4,0.33,"Not Significant",Adjusted,Extracted
c0d2f84e38d5,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019",Diabetes,AHR=1.04,0.44,2.45,0.93,"Not Significant",Adjusted,Extracted
d17335f6c72e,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","Cerebrovascular disease",AHR=1.42,0.39,5.16,0.6,"Not Significant",Adjusted,Extracted
fa1f461f0442,"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019",Age,AHR=1.01,0.98,1.05,0.38,"Not Significant",Adjusted,Extracted
04b6969df8d5,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Heart Failure","HR 2.3",1.6,3.2,,Significant,Adjusted,Extracted
1b9b505bdf84,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Heart Disease","HR 1.7",1.2,2.5,,Significant,"Not Adjusted",Extracted
215df113940e,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Male gender","HR 1.6",1.2,2.1,,Significant,"Not Adjusted",Extracted
42b8c731f526,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Heart Disease","HR 1.7",1.25,2.5,,Significant,Adjusted,Extracted
7b19cfba45d6,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio",Dementia,"HR 1.8",1.1,2.8,,Significant,"Not Adjusted",Extracted
885e4ebebc71,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio",Cancer,"HR 1.4",1.0,2.0,,"Not Significant","Not Adjusted",Extracted
8991e5e8b7ea,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio",Cancer,"HR 1.4",1.0,2.0,,Significant,Adjusted,Extracted
a1b7179e2160,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Chronic kidney disease","HR 1.5",0.9,2.6,,Significant,Adjusted,Extracted
bc838c58b33b,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Overweight or obese","HR 1.3",0.6,2.9,,Significant,Adjusted,Extracted
bf1501ab54ad,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Male gender","HR 1.6",1.2,2.1,,Significant,"Not Adjusted",Extracted
d41ee853c1f4,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Chronic kidney disease","HR 1.5",0.9,2.6,,"Not Significant","Not Adjusted",Extracted
da6a76f658ff,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio",Dementia,"HR 1.8",1.1,2.5,,Significant,Adjusted,Extracted
db8a5932bc5c,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio",COPD,"HR 1.1",0.7,1.7,,"Not Significant",Adjusted,Extracted
e9c5e5ab903b,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio",COPD,"HR 1.1",0.7,1.7,,"Not Significant","Not Adjusted",Extracted
fd845c13d111,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio","Overweight or obese","HR 1.3",0.6,2.9,,"Not Significant","Not Adjusted",Extracted
12b0859bac33,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System",Cancer,"OR 1.14",0.95,1.37,0.17,"Not Significant","Not Adjusted",Calculated
15ad88c645ff,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Overweight or obese","OR 0.90",0.77,1.05,0.2,"Not Significant","Not Adjusted",Calculated
201d276fb37d,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System",Diabetes,"OR 1.13",1.0,1.27,0.05,Significant,"Not Adjusted",Calculated
3d8ecc5002f3,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System",Asthma,"OR 0.82",0.66,1.04,0.1,"Not Significant","Not Adjusted",Calculated
3e96afe854d6,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Chronic liver disease","OR 0.86",0.61,1.2,0.37,"Not Significant","Not Adjusted",Calculated
3f7b6ca6ee27,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Race_ Black vs","OR 0.89",0.79,1.0,0.05,"Not Significant","Not Adjusted",Calculated
556e4450d194,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Ethnicity_ Hispanic vs","OR 0.53",0.43,0.64,0,Significant,"Not Adjusted",Calculated
967d797a3855,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Heart Failure","OR 1.41",1.15,1.72,0,Significant,"Not Adjusted",Calculated
a6c4ad3f1ada,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Male gender","OR 1.09",0.97,1.22,0.16,"Not Significant","Not Adjusted",Calculated
a871bff1180e,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Chronic kidney disease","OR 1.60",1.36,1.89,0,Significant,"Not Adjusted",Calculated
c2784e5a2df8,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Immune system disorders","OR 0.71",0.43,1.16,0.17,"Not Significant","Not Adjusted",Calculated
ce59e4dde423,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System",Hypertension,"OR 1.03",0.92,1.15,0.64,"Not Significant","Not Adjusted",Calculated
e01166cc1ee3,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System",COPD,"OR 1.11",0.83,1.48,0.48,"Not Significant","Not Adjusted",Calculated
e54384a38795,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Heart Disease","OR 1.31",1.16,1.49,0,Significant,"Not Adjusted",Calculated
e79ea9233b69,"Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System","Race_ Asian vs","OR 0.65",0.49,0.87,0.00,Significant,"Not Adjusted",Calculated
0188dbff6232,"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy",Diabetes,"OR 3.47",1.02,11.82,0.05,Significant,"Not Adjusted",Calculated
6aa303c9ddd5,"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","Heart Failure","OR 4.76",1.43,15.87,0.01,Significant,"Not Adjusted",Calculated
9b0de6e8b11e,"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","Heart Disease","OR 3.47",1.02,11.82,0.05,Significant,"Not Adjusted",Calculated
a20c39e73f2f,"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","Overweight or obese","OR 1.16",0.32,4.23,0.82,"Not Significant","Not Adjusted",Calculated
cd8651879052,"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy",Hypertension,"OR 0.56",0.16,2.01,0.38,"Not Significant","Not Adjusted",Calculated
ff7d5a9ac402,"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","Chronic kidney disease","OR 6.44",1.74,23.84,0.01,Significant,"Not Adjusted",Calculated
0b7b7366e234,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Male gender",AOR=2.1,1.7,2.7,,Significant,Adjusted,Extracted
15e308420876,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Male gender",AOR=2.1,1.7,2.6,,Significant,Adjusted,Extracted
19cacc7805a2,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Autoimmune disorders",AOR=1.0,0.7,1.5,,"Not Significant",Adjusted,Extracted
2b68b6628e93,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Male gender",OR=1.9,1.6,2.3,,Significant,"Not Adjusted",Extracted
356b1d33f8c6,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Overweight or obese",AOR=1.5,1.1,2.1,,Significant,Adjusted,Extracted
4289bc08abe8,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Cerebrovascular disease",AOR=1.4,1.1,1.8,,Significant,Adjusted,Extracted
54d8820675e4,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Heart Disease",OR=5.0,4.1,6.1,,Significant,"Not Adjusted",Extracted
5e80105da12d,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Diabetes,AOR=1.6,1.3,2.1,,Significant,Adjusted,Extracted
64ca2027cc72,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Chronic respiratory diseases",OR=2.7,2.2,3.3,,Significant,"Not Adjusted",Extracted
6542ac5f6637,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Chronic respiratory diseases",AOR=1.4,1.1,1.8,,Significant,Adjusted,Extracted
772538c1f248,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Cancer,OR=4.5,3.6,5.5,,Significant,"Not Adjusted",Extracted
78d8dd255bb7,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Hypertension,OR=8.9,7.3,10.8,,Significant,"Not Adjusted",Extracted
81856b0326ff,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Cerebrovascular disease",OR=7.2,5.8,9.0,,Significant,"Not Adjusted",Extracted
81c85fb90a2b,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Overweight or obese",OR=1.2,0.9,1.6,,"Not Significant","Not Adjusted",Extracted
94e56da6f7bb,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Dementia,AOR=1.9,1.4,2.5,,Significant,Adjusted,Extracted
b28ff63885d5,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Heart Failure",AOR=1.7,1.3,2.2,,Significant,Adjusted,Extracted
b934c2fdbc21,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Drinking,OR=2.5,1.8,3.7,,Significant,"Not Adjusted",Extracted
bc1ae2326e3a,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Chronic liver disease",OR=1.7,1.0,3.1,,Significant,"Not Adjusted",Extracted
c77db4382d43,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Heart Disease",AOR=1.2,0.9,1.5,,"Not Significant",Adjusted,Extracted
dd3b45eb86ba,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Drinking,AOR=1.6,1.1,2.5,,Significant,Adjusted,Extracted
e2f64aa7a095,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Diabetes,OR=4.4,3.6,5.4,,Significant,"Not Adjusted",Extracted
e606cf355967,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Dementia,OR=11.9,9.3,15.3,,Significant,"Not Adjusted",Extracted
ecd9b9e04c4c,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Hypertension,AOR=1.3,1.1,1.7,,Significant,Adjusted,Extracted
eea3fa58b9bb,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Chronic liver disease",AOR=1.6,0.8,3.0,,"Not Significant",Adjusted,Extracted
f4d3fb19a2b4,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",Cancer,AOR=1.3,1.0,1.7,,Significant,Adjusted,Extracted
fc73f0716ee4,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Heart Failure",OR=9.1,7.0,11.8,,Significant,"Not Adjusted",Extracted
ff4860df8073,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort","Autoimmune disorders",OR=2.8,2.0,3.8,,Significant,"Not Adjusted",Extracted
df81d6c366dc,"Characteristics of COVID-19 infection in Beijing","Male gender",,,,,,,
2de5c1480374,"Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China","Chronic respiratory diseases","OR 5.44",2.45,12.06,<0.01,Significant,"Not Adjusted",Calculated
d946414031dd,"Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China","Smoking Status","OR 1.40",0.62,3.18,0.42,"Not Significant","Not Adjusted",Calculated
b76ef8c7bfb7,"Characterization and Clinical Course of 1000 Patients with COVID-19 in New York: retrospective case series","Chronic kidney disease",,,,,,,
7e3d6ff42b09,"Characterization of clinical progression of COVID-19 patients in Shenzhen, China",Hypertension,,,,,,,
26fa283328f2,"Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)",COPD,,,,,,,
240d0267dac7,"Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV","Heart Failure","OR 8.19",2.45,27.34,<0.01,Significant,"Not Adjusted",Calculated
fc7188322948,"Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City","Male gender",,,,,,,
5aa2a5e02f9e,"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication",Age,AOR=1.09,1.07,1.12,,Significant,Adjusted,Extracted
983bb0e971f2,"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication",Age,OR=1.10,1.08,1.12,,Significant,"Not Adjusted",Extracted
48e9f0e33967,"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.","Heart Disease",OR=8.29,5.02,13.68,,Significant,"Not Adjusted",Extracted
78e0a7707819,"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.",Diabetes,OR=2.51,1.53,4.13,,Significant,"Not Adjusted",Extracted
9388d79d6e0c,"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.","Chronic kidney disease",OR=13.91,7.23,26.8,,Significant,"Not Adjusted",Extracted
cb6c5bf49a62,"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.","Chronic respiratory diseases",OR=4.38,1.74,11.03,,Significant,"Not Adjusted",Extracted
f14e9fbe92ae,"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.",Hypertension,OR=3.48,2.24,5.4,,Significant,"Not Adjusted",Extracted
29c301f7d0c9,"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes",Hypertension,"OR 2.49",9.35,0.0,,Significant,"Not Adjusted",Calculated
696e9823f7c6,"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes",Diabetes,"OR 2.16",10.57,0.0,,Significant,"Not Adjusted",Calculated
dd47e3e5ebff,"Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study","Male gender",,,,,,,
434c02ec5d2e,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study","Male gender","OR 0.88",3.11,0.12,,"Not Significant","Not Adjusted",Calculated
602769384d38,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study",Diabetes,"OR 1.13",4.17,0.02,,Significant,"Not Adjusted",Calculated
02bbcbb5edf9,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.","Chronic respiratory diseases","OR 1.16",8.05,0.02,,Significant,"Not Adjusted",Calculated
47fea82b8c1d,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.","Cerebrovascular disease","OR 2.10",18.92,0.0,,Significant,"Not Adjusted",Calculated
df5cc9167df2,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.",Hypertension,"OR 1.78",6.69,0.0,,Significant,"Not Adjusted",Calculated
f6e23fb0db6b,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.","Heart Disease","OR 1.99",8.1,0.0,,Significant,"Not Adjusted",Calculated
06748e552548,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China","Male gender",,,,,,,
5cd8c06f7ae7,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China","Heart Disease",,,,,,,
76df9adb420b,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China",Hypertension,,,,,,,
82a55416e373,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China","Male gender",,,,,,,
bf374270d6c5,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China",Diabetes,,,,,,,
c1650e51486c,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China","Heart Disease",,,,,,,
d5c1e4b0d073,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China",Diabetes,,,,,,,
ebd993dfd4ee,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China",Hypertension,,,,,,,
0a8bc5a716ed,"Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study","Heart Disease",,,,,,,
504c1b9a27bc,"Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study",Dementia,,,,,,,
64848c4f8e0b,"Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study",COPD,,,,,,,
6c25ce0948fb,"Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study",Diabetes,,,,,,,
811bd4cf4cfc,"Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study","Smoking Status",,,,,,,
aa67cacee6fc,"Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study",Hypertension,,,,,,,
712f07ffcfe5,"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China",Diabetes,,,,,,,
d00c93948d0f,"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China",Hypertension,,,,,,,
df270dc0a66c,"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China","Male gender",,,,,,,
112099211922,"Clinical characteristics of 2019 novel coronavirus infection in China",COPD,,,,,,,
26700b69e474,"Clinical characteristics of 2019 novel coronavirus infection in China","Smoking Status",,,,,,,
0c2531a94ccd,"Clinical Characteristics of Coronavirus Disease 2019 in China","Smoking Status",,,,,,,
738296ee95a6,"Clinical Characteristics of Coronavirus Disease 2019 in China","Smoking Status",,,,,,,
9dd652c3ec57,"Clinical Characteristics of Coronavirus Disease 2019 in China",COPD,,,,,,,
faf96cf83605,"Clinical Characteristics of Coronavirus Disease 2019 in China",COPD,,,,,,,
370cae7041e9,"Clinical Characteristics of Covid-19 in New York City","Heart Disease",,,,,,,
5fe871595410,"Clinical Characteristics of Covid-19 in New York City","Overweight or obese",,,,,,,
6f700efc08cd,"Clinical Characteristics of Covid-19 in New York City",COPD,,,,,,,
d45a784f5c17,"Clinical Characteristics of Covid-19 in New York City","Male gender",,,,,,,
dc71225120e1,"Clinical Characteristics of Covid-19 in New York City",Asthma,,,,,,,
fe35945b70ab,"Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China",Age,,,,,,,
014c42c79ec7,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Heart Disease","OR 2.98",2.12,4.18,<0.01,Significant,"Not Adjusted",Calculated
07f6311265d6,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City",Cancer,"OR 1.53",0.9,2.58,0.11,"Not Significant","Not Adjusted",Calculated
0834b41ed8ae,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Ethnicity_ Hispanic vs","OR 0.65",0.47,0.91,<0.05,Significant,"Not Adjusted",Calculated
0a26e80525e2,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Cerebrovascular disease","OR 2.10",1.29,3.4,<0.05,Significant,"Not Adjusted",Calculated
178b344ba0c5,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City",Hypertension,"OR 1.89",1.44,2.48,<0.05,Significant,"Not Adjusted",Calculated
3db65ec980a5,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Race_ Black vs","OR 0.86",0.59,1.22,0.37,"Not Significant","Not Adjusted",Calculated
45806598586b,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Male gender","OR 1.22",0.93,1.6,0.14,"Not Significant","Not Adjusted",Calculated
81c809d7d7d4,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Heart Disease","OR 2.98",2.12,4.18,<0.05,Significant,"Not Adjusted",Calculated
8a97f507f247,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Race_ Asian vs","OR 1.70",0.87,3.35,0.12,"Not Significant","Not Adjusted",Calculated
c3eb760957cc,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City",Diabetes,"OR 2.09",1.56,2.81,<0.05,Significant,"Not Adjusted",Calculated
c8ef48ca619c,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Chronic kidney disease","OR 2.02",1.31,3.1,<0.05,Significant,"Not Adjusted",Calculated
c995f5fb52db,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City","Heart Failure","OR 3.51",2.37,5.19,<0.05,Significant,"Not Adjusted",Calculated
df60f62ff383,"Clinical Characteristics of Hospitalized Covid-19 Patients in New York City",Asthma,"OR 0.93",0.56,1.53,0.77,"Not Significant","Not Adjusted",Calculated
7080a158a649,"Clinical characteristics of patients diagnosed with COVID-19 in Beijing",Hypertension,,,,,,,
ec4093b3e004,"Clinical characteristics of patients diagnosed with COVID-19 in Beijing","Male gender",,,,,,,
4ad9428fda0d,"Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China","Smoking Status",,,,,,,
1868c677ece1,"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study","Male gender",OR=3.86,1.8,8.25,<0.05,Significant,"Not Adjusted",Extracted
a396702b0196,"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study","Heart Disease","OR 2.00",0.65,6.12,0.22,"Not Significant","Not Adjusted",Calculated
aed50ab3e9c0,"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study","Male gender",AOR=3.86,1.57,9.5,<0.05,Significant,Adjusted,Extracted
f2fcec175203,"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study",Hypertension,"OR 0.74",0.34,1.59,0.44,"Not Significant","Not Adjusted",Calculated
ee71f02d2d26,"Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience","Smoking Status",AOR=10.09,1.22,83.4,<0.05,Significant,Adjusted,Extracted
fc5bb40c18b6,"Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience",Asthma,AOR=4.92,1.03,23.44,<0.05,Significant,Adjusted,Extracted
9f5b2c12f425,"Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China",Hypertension,"OR 5.00",1.75,14.3,<0.01,Significant,"Not Adjusted",Calculated
b860ba5ff7b4,"Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China","Heart Disease","OR 7.97",2.29,27.75,<0.01,Significant,"Not Adjusted",Calculated
c0adfc032c1b,"Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China",Diabetes,"OR 4.88",1.31,18.18,0.02,Significant,"Not Adjusted",Calculated
29016dd1e83d,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","Smoking Status","OR 2.23",0.65,7.63,0.2,"Not Significant","Not Adjusted",Calculated
2e033a3384c4,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","Smoking Status","OR: 2.23",0.65,7.63,0.2,"Not Significant","Not Adjusted",Calculated
34edea68de60,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","Smoking Status",OR=2.23,0.65,7.63,0.2,"Not Significant","Not Adjusted",Extracted
5f658a2c3b0d,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",Age,AOR=1.10,1.03,1.17,<0.05,Significant,Adjusted,Extracted
bcdb310bbf1c,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",Age,OR=1.14,1.09,1.18,<0.05,Significant,"Not Adjusted",Extracted
0b73453bb582,"Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study","Race_ Black vs",,,,,,,
19a152661bf6,"Clinical determinants for fatality of 44,672 patients with COVID-19",Hypertension,"OR 3.05",2.56,3.62,<0.01,Significant,"Not Adjusted","Extracted RR, Calculated OR"
983da351cd33,"Clinical determinants for fatality of 44,672 patients with COVID-19",Diabetes,"OR 3.54",2.79,4.48,<0.01,Significant,"Not Adjusted","Extracted RR, Calculated OR"
9d439ed62765,"Clinical determinants for fatality of 44,672 patients with COVID-19","Heart Disease","OR 5.42",4.33,6.8,<0.01,Significant,"Not Adjusted","Extracted RR, Calculated OR"
ff85e9321ee8,"Clinical determinants for fatality of 44,672 patients with COVID-19","Male gender","OR 1.69",1.48,1.92,<0.01,Significant,"Not Adjusted","Extracted RR, Calculated OR"
406a32fb7056,"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China",Diabetes,,,,,,,
6ba7198e7d99,"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China","Heart Disease",,,,,,,
a40753aa9105,"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China",Hypertension,,,,,,,
3914e48e649f,"Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19",Hypertension,HR=2.3,1.5,3.6,<0.05,Significant,"Not Adjusted",Extracted
715be9e7faba,"Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19","Chronic kidney disease",HR=4.2,1.7,10.5,<0.05,Significant,"Not Adjusted",Extracted
72a009200eb5,"Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19",COPD,HR=3.1,1.8,5.4,<0.05,Significant,"Not Adjusted",Extracted
aefa4d977b79,"Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19",Cancer,HR=1.2,0.5,3.4,0.68,"Not Significant","Not Adjusted",Extracted
c7ccdcd853dd,"Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19",Diabetes,HR=1.1,0.6,1.9,0.88,"Not Significant","Not Adjusted",Extracted
eaf2e28a4c68,"Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19","Heart Disease",HR=1.8,1.1,2.9,<0.05,Significant,"Not Adjusted",Extracted
5f4beefb347a,"Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort","Chronic respiratory diseases","OR 0.86",0.29,2.5,0.78,"Not Significant","Not Adjusted",Calculated
7bbc2d75ee49,"Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort","Chronic kidney disease","OR 1.58",0.52,4.77,0.42,"Not Significant","Not Adjusted",Calculated
f85f660f0854,"Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort","Heart Failure","OR 4.51",1.39,14.61,0.01,Significant,"Not Adjusted",Calculated
7454df39350c,"Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.","Male gender",,,,,,,
a29aeac7afb8,"Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.","Overweight or obese",,,,,,,
a9914da1491d,"Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.","Overweight or obese",,,,,,,
d8a7059ba354,"Clinical Presentation of COVID19 in Dementia Patients",Dementia,OR=1.84,1.08,3.13,<0.05,Significant,Adjusted,Extracted
f08ff92bfe4b,"Clinical Presentation of COVID19 in Dementia Patients",Age,OR=1.09,1.07,1.12,<0.05,Significant,Adjusted,Extracted
d418d5f3f61f,"Clinical progression of patients with COVID-19 in Shanghai, China",Age,,,,,,,
d467f2e3a937,"Clinical progression of patients with COVID-19 in Shanghai, China",Age,,,,,,,
b513e77e739f,"Cohort profile: Preliminary experience of 500 COVID-19 postive cases at a South West London District General Hospital.","Male gender","OR 1.34",0.88,2.05,0.17,"Not Significant","Not Adjusted",Calculated
3fbb7bf72577,"Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis",Diabetes,,,,,,,
52031eb9e93c,"Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis","Heart Disease",,,,,,,
7017ddd927e2,"Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis",Cancer,,,,,,,
ebb0b65cc3c9,"Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis [medrxiv]",COPD,,,,,,,
b9aa813d0617,"Compassionate Use of Remdesivir for Patients with Severe Covid-19","Male gender",,,,,,,
01babcfaf37b,"Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis",Diabetes,,,,,,,
079943020cc8,"Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis","Heart Failure",,,,,,,
2d9d87cff415,"Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis","Smoking Status",,,,,,,
7abc80bf12f2,"Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis","Heart Disease",,,,,,,
5688c6d0a448,"Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up",Age,"HR  1.08",1.06,1.11,<0.01,Significant,"Not Adjusted",Extracted
655cacf24c4f,"Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up",Age,"AHR 1.06",1.03,1.1,<0.01,Significant,Adjusted,Extracted
f6da362a4cbe,"Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up","Cerebrovascular disease","HR 3.26",1.66,6.4,<0.01,Significant,"Not Adjusted",Extracted
da22295aa3c3,"Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up [Journal of Infection]",COPD,"AHR 2.24",1.12,4.5,0.02,Significant,Adjusted,Extracted
0007c3dc5257,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort","Male gender","AOR 2.02",0.79,5.18,0.14,"Not Significant",Adjusted,Extracted
2ac2eb32b34a,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort","Male gender","OR 1.76",0.98,3.23,0.06,"Not Significant","Not Adjusted",Extracted
2bca890051bc,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort","Race_ Other vs","OR 1.99",0.84,4.71,0.12,"Not Significant","Not Adjusted",Calculated
4b1e18ae1bbd,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort",Diabetes,"OR 1.68",0.94,3.01,0.08,"Not Significant","Not Adjusted",Calculated
5c2f977b6bb0,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort",Age,"AOR 1.08",1.04,1.12,<0.01,Significant,Adjusted,Extracted
7e16fde0be25,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort",Age,"OR 1.06",1.03,1.08,<0.01,Significant,"Not Adjusted",Extracted
8ad23c035b50,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort",Hypertension,"OR 1.83",0.97,3.44,0.06,"Not Significant","Not Adjusted",Calculated
9b2553885804,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort","Ethnicity_ Hispanic vs","OR 0.59",0.31,1.11,0.1,"Not Significant","Not Adjusted",Calculated
ab4fb33723aa,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort","Chronic kidney disease","OR 1.35",0.65,2.81,0.42,"Not Significant","Not Adjusted",Calculated
bf7867495fe3,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort","Chronic respiratory diseases","OR 0.95",0.48,1.86,0.88,"Not Significant","Not Adjusted",Calculated
e6e92e52781b,"Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort","Race_ Black vs","OR 1.95",0.82,4.63,0.13,"Not Significant","Not Adjusted",Calculated
067f42876574,"Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans","Ethnicity_ Hispanic vs",AOR=1.80,1.63,1.99,,Significant,Adjusted,Extracted
6ad92fc32574,"Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans","Ethnicity_ Hispanic vs",AOR=2.25,2.04,2.49,,Significant,Adjusted,Extracted
8eafbadb15dc,"Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans","Race_ Black vs",AOR=3.13,2.94,3.33,,Significant,Adjusted,Extracted
ce59199f18a0,"Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans","Race_ Black vs",AOR=2.83,2.65,3.03,,Significant,Adjusted,Extracted
03123c5cd7ef,"COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes",Hypertension,,,,,,,
3709153e7619,"COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes",Diabetes,,,,,,,
fd8696bf7d17,"COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes","Male gender",,,,,,,
6398f59a8069,"COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter","Heart Disease",,,,,,,
dda503f99bb7,"COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter",Diabetes,,,,,,,
1f0eca221328,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","Race_ Black vs",,,,,,,
341fb9a9307b,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter",Hypertension,,,,,,,
6a9469f1e298,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter",Diabetes,,,,,,,
b0736a24c156,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","Chronic respiratory diseases",,,,,,,
b624a19d3c8b,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","Chronic kidney disease",,,,,,,
c26616bac4c8,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter",Hypertension,,,,,,,
cc7e29ac62a0,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","Ethnicity_ Hispanic vs",,,,,,,
f96f85c04856,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","Ethnicity_ Hispanic vs",,,,,,,
fd58c8b43614,"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","Male gender",,,,,,,
29cf70ac5ffe,"COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author","Male gender","OR 1.26",0.6,2.64,0.54,"Not Significant","Not Adjusted",Calculated
60c73999fb13,"COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author","Chronic kidney disease","OR 2.36",1.12,4.99,0.02,Significant,"Not Adjusted",Calculated
9f5aae416cc0,"COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author",Hypertension,"OR 0.80",0.33,1.92,0.62,"Not Significant","Not Adjusted",Calculated
c9ca5b4ecb3d,"COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author","Race_ Black vs","OR 0.42",0.16,1.1,0.07,"Not Significant","Not Adjusted",Calculated
f6a4fdd4d3f1,"COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author",COPD,"OR 1.16",0.54,2.51,0.71,"Not Significant","Not Adjusted",Calculated
fe7b802310c7,"COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author","Heart Disease","OR 2.39",1.14,5.05,0.02,Significant,"Not Adjusted",Calculated
282e328cb491,"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years","Chronic kidney disease",,,,,,,
3289ae7d5602,"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years","Chronic kidney disease",,,,,,,
3ec900b1eded,"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years",COPD,,,,,,,
474b55d882c3,"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years","Ethnicity_ Hispanic vs",,,,,,,
71bf431a7c72,"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years",COPD,,,,,,,
c5cee78ce847,"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years",COPD,,,,,,,
d0b5b0852fd8,"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years","Chronic kidney disease",,,,,,,
39648e84cd3f,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features",Drinking,,,,,,,
66c870d4b16f,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features",Cancer,,,,,,,
7a28747bd9d4,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features",Diabetes,,,,,,,
9a4636c8afdc,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features",Hypertension,,,,,,,
9f336b4fd46b,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features","Male gender",,,,,,,
d53165fccdf5,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features",COPD,,,,,,,
e2a8ad387dd2,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features","Heart Disease",,,,,,,
e98717b97eac,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features","Smoking Status",,,,,,,
f743dc2bb3be,"COVID-19 with Different Severities: A Multicenter Study of Clinical Features","Cerebrovascular disease",,,,,,,
033713fcf3c1,"COVID-19: Impact of Obesity and Diabetes in Disease Severity",Hypertension,,,,,,,
0cad4776a3ab,"COVID-19: Impact of Obesity and Diabetes in Disease Severity",Diabetes,,,,,,,
4641983a6d6e,"COVID-19: Impact of Obesity and Diabetes in Disease Severity","Overweight or obese",,,,,,,
46e93c1f9db3,"COVID-19: Impact of Obesity and Diabetes in Disease Severity","Male gender",,,,,,,
47a72310ac98,"COVID-19: Impact of Obesity and Diabetes in Disease Severity","Overweight or obese",,,,,,,
49f41552c7f2,"COVID-19: Impact of Obesity and Diabetes in Disease Severity",Diabetes,,,,,,,
6ea03ef31863,"COVID-19: Impact of Obesity and Diabetes in Disease Severity","Male gender",,,,,,,
94b11a73e748,"COVID-19: Impact of Obesity and Diabetes in Disease Severity",Hypertension,,,,,,,
c82dc984eb08,"COVID-19: Impact of Obesity and Diabetes in Disease Severity","Male gender",,,,,,,
ef37ab8af35c,"COVID-19: Impact of Obesity and Diabetes in Disease Severity",Hypertension,,,,,,,
ab88585f5eb0,"Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19","Smoking Status","OR 0.93",0.26,3.27,0.91,"Not Significant","Not Adjusted",Calculated
00ec76149c4a,"Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.","Chronic kidney disease",,,,,,,
2bccde3fac0d,"Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.","Heart Disease",,,,,,,
449ab3087a75,"Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.",Diabetes,,,,,,,
5114812162c8,"Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.","Cerebrovascular disease",,,,,,,
8d1d4fa850d3,"Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.","Smoking Status",,,,,,,
bc9aa00427c4,"Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.",Cancer,,,,,,,
ec9d08b2b8b0,"Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.",COPD,,,,,,,
f9182bc5cc50,"Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.",Hypertension,,,,,,,
871fb9b3bf93,"Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients",Diabetes,OR=1.65,1.35,1.96,,Significant,"Not Adjusted",Extracted
92cdc092e50c,"Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York City. Title: Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York",Cancer,"RR 1.15",0.84,1.57,,"Not Significant","Not Adjusted",Extracted
06f2fdf4428c,"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis",COPD,,,,,,,
4fb663ff05fa,"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis","Chronic kidney disease",,,,,,,
5cd1f55d2d3f,"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis",Cancer,,,,,,,
a5f1c8c11e75,"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis","Heart Disease",,,,,,,
a79cbe64fa63,"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis","Chronic liver disease",,,,,,,
ab4477f444a2,"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis","Cerebrovascular disease",,,,,,,
2dc984e99639,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico","Smoking Status","OR .95",1.47,0.14,,"Not Significant","Not Adjusted",Calculated
2f971b654587,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico","Overweight or obese","OR 1.51",2.03,0.0,,Significant,"Not Adjusted",Calculated
7088fe7763c9,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico","Chronic kidney disease","OR 2.93",5.35,0.0,,Significant,"Not Adjusted",Calculated
74cc8e250823,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico",Asthma,"OR 0.61",1.29,0.53,,"Not Significant","Not Adjusted",Calculated
cae909df15e5,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico",Hypertension,"OR 2.61",3.43,0.0,,Significant,"Not Adjusted",Calculated
d1fa00f564c9,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico",Diabetes,"OR 2.70",3.58,0.0,,Significant,"Not Adjusted",Calculated
dd4b0561ae39,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico",COPD,"OR 3.39",5.8,0.0,,Significant,"Not Adjusted",Calculated
ddc360975d4b,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico","Heart Disease","OR 1.90",3.36,0.0,,Significant,"Not Adjusted",Calculated
f3d4efb837a2,"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico","Male gender","OR 1.50",1.99,0.0,,Significant,"Not Adjusted",Calculated
6e7363fd1a53,"Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.","Smoking Status","OR 1.31",0.48,3.62,0.6,"Not Significant","Not Adjusted",Calculated
7d2e1c4b0214,"Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.","Respiratory system diseases","OR 2.55",0.86,7.55,0.09,"Not Significant","Not Adjusted",Calculated
bcf031c8508f,"Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.",Hypertension,"OR 5.42",1.88,15.62,<0.05,Significant,"Not Adjusted",Calculated
188953190cec,"Early prediction of mortality risk among severe COVID-19 patients using machine learning","Chronic respiratory diseases","OR 3.76",1.23,11.52,0.02,Significant,"Not Adjusted",Calculated
3bd3d4f6f9f1,"Early prediction of mortality risk among severe COVID-19 patients using machine learning","Male gender","OR 2.83",1.47,5.42,<0.01,Significant,"Not Adjusted",Calculated
3058b9a3be8a,"Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea",Cancer,,,,,,,
574f7679ab00,"Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea",Dementia,,,,,,,
67920b64bf32,"Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea","Male gender",,,,,,,
73a6cfe4196f,"Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea",Hypertension,,,,,,,
8e760e82bbd3,"Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea",Diabetes,,,,,,,
a44123f0f029,"Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea","Cerebrovascular disease",,,,,,,
04272f08b0c4,"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis","Chronic liver disease",OR=1.44,1.21,1.71,,Significant,"Not Adjusted",Extracted
5da00225b46a,"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis","Chronic respiratory diseases",OR=2.02,1.8,2.26,,Significant,"Not Adjusted",Extracted
8d1bec38a9a4,"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis",Hypertension,OR=3.35,2.53,4.42,,Significant,"Not Adjusted",Extracted
9b850b1f26ee,"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis","Heart Disease",OR=3.32,2.79,3.95,,Significant,"Not Adjusted",Extracted
b11cb926a4b6,"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis","Cerebrovascular disease",OR=4.12,3.04,5.58,,Significant,"Not Adjusted",Extracted
b5ca3d6e977e,"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis","Chronic digestive disorders",OR=1.33,0.56,3.19,,"Not Significant","Not Adjusted",Extracted
c63db5355758,"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis",Cancer,OR=2.22,1.63,3.03,,Significant,"Not Adjusted",Extracted
f2457aa73a90,"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis","Respiratory system diseases",OR=2.02,1.8,2.26,,Significant,"Not Adjusted",Extracted
1db3f40d7120,"Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China","Heart Disease",,,,,,,
347e7b925fa3,"Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China","Overweight or obese",,,,,,,
65da68e13318,"Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China",Hypertension,,,,,,,
b62420d35d47,"Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China","Male gender",,,,,,,
cd5fdef8e333,"Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China",Diabetes,,,,,,,
dc4b89d94b04,"Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China",Drinking,,,,,,,
537bd6f613e6,"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China","Smoking Status",,,,,,,
020bae775efe,"Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study","Smoking Status",,,,,,,
15b6c2550456,"Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study","Overweight or obese",,,,,,,
1ec8ffa08743,"Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study","Respiratory system diseases",,,,,,,
6227f386bbeb,"Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study",Age,,,,,,,
7b1333f28ca6,"Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study","Chronic respiratory diseases",,,,,,,
20d59dfdc85b,"Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study [medrxiv]","Chronic respiratory diseases",,,,,,,
beb823337c4f,"Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China",Age,,,,,,,
e0c2cae5ada2,"Epidemiological characteristics of confirmed COVID-19 cases in Tianjin",Age,,,,,,,
f2ebeb100805,"Epidemiological characteristics of confirmed COVID-19 cases in Tianjin","Cerebrovascular disease",,,,,,,
144aaa7ba116,"Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study","Chronic respiratory diseases","OR 2.24",1.09,4.6,0.03,Significant,"Not Adjusted",Calculated
9a1aa3b13c18,"Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study",Hypertension,"OR 1.98",0.93,4.22,0.08,"Not Significant","Not Adjusted",Calculated
f039a2ce8915,"Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study","Male gender",OR=1.05,1.04,1.06,<0.05,Significant,"Not Adjusted",Extracted
132fa16a0568,"Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology]",Age,"OR 1.05",1.04,1.06,<0.01,Significant,"Not Adjusted",Extracted
189609e54df5,"Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology]","Male gender","OR 1.45",1.08,1.96,0.01,Significant,"Not Adjusted",Extracted
4b6fb636917e,"Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology]",Diabetes,"OR 1.24",0.66,2.34,0.51,"Not Significant","Not Adjusted",Calculated
927ef093cf3e,"Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology]","Chronic respiratory diseases","OR 2.05",1.0,4.22,0.05,"Not Significant","Not Adjusted",Calculated
8670cba4dde1,"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings",Cancer,,,,,,,
00db7337bf8c,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Race_ Black vs","OR 0.32",1.92,0.59,,"Not Significant","Not Adjusted",Calculated
10b2d7b6ed94,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",Diabetes,HR=1.65,1.11,2.44,,Significant,"Not Adjusted",Extracted
19b2f248c763,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",Hypertension,AHR=1.58,0.89,2.81,,"Not Significant",Adjusted,Extracted
25dddc822ebe,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Chronic respiratory diseases",HR=3.15,1.84,5.39,,Significant,"Not Adjusted",Extracted
28ad00cf9b5d,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",Age,"HR 1.05",1.03,1.07,,Significant,"Not Adjusted",Extracted
2ec83cacbf52,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Overweight or obese",HR=0.76,0.4,1.47,,"Not Significant","Not Adjusted",Extracted
398772d3b8fa,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Male gender","HR 0.96",0.61,1.5,,"Not Significant","Not Adjusted",Extracted
4023adc0b848,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",Age,"AHR 1.04",1.02,1.06,,Significant,Adjusted,Extracted
4bf3fa4fc97b,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Ethnicity_ Hispanic vs","OR 0.33",1.52,0.37,,"Not Significant","Not Adjusted",Calculated
52ee42dd2f25,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Overweight or obese","HR 0.74",0.43,1.27,,"Not Significant","Not Adjusted",Extracted
5f45c1a8c6aa,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Heart Disease","HR 0.62",0.33,1.17,,Significant,"Not Adjusted",Extracted
605ce3965fc0,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",Diabetes,"AHR 1.28",0.77,2.13,,"Not Significant",Adjusted,Extracted
62279c94fdd3,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Heart Disease",AHR=1.76,1.08,2.86,,Significant,Adjusted,Extracted
748f6d79a49b,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",Diabetes,AHR=1.31,0.81,2.1,,"Not Significant",Adjusted,Extracted
764296daa2c4,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",Hypertension,HR=2.24,1.4,3.59,,Significant,"Not Adjusted",Extracted
8cbcbf7a7501,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Chronic respiratory diseases","AHR 4.22",2.02,8.84,,Significant,Adjusted,Extracted
8f8570a962f9,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Chronic respiratory diseases","HR 3.45",2.0,5.97,,Significant,"Not Adjusted",Extracted
b1c9fa123c10,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Chronic respiratory diseases",AHR=2.94,1.48,5.84,,Significant,Adjusted,Extracted
be6ed791daf0,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Chronic kidney disease",HR=1.50,0.92,2.45,,"Not Significant","Not Adjusted",Extracted
c587ec2aecb0,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Male gender","AHR 1.35",0.8,2.25,,"Not Significant",Adjusted,Extracted
cc403c53eae4,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Chronic kidney disease","HR 1.58",0.94,2.66,,"Not Significant","Not Adjusted",Extracted
cdab407dbc43,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Heart Disease","AHR 0.69",0.34,1.42,,"Not Significant",Adjusted,Extracted
ddc474721502,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Overweight or obese","AHR 0.94",0.55,1.77,,"Not Significant",Adjusted,Extracted
e665129c645e,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Heart Disease",HR=2.21,1.44,3.39,,Significant,"Not Adjusted",Extracted
f85638e66f51,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","Chronic kidney disease","AHR 1.46",0.81,2.13,,"Not Significant",Adjusted,Extracted
fc09cd799086,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",Diabetes,"HR 0.89",0.57,1.39,,"Not Significant","Not Adjusted",Extracted
281aafc3a8dc,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information",Diabetes,"OR 1.59",1.38,1.83,<0.01,Significant,"Not Adjusted",Calculated
36f38882e818,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information","Male gender","OR 1.22",1.07,1.39,<0.01,Significant,"Not Adjusted",Calculated
7bca14f72027,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information","Chronic kidney disease","OR 3.15",2.5,3.95,<0.01,Significant,"Not Adjusted",Calculated
814f4f782564,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information","Heart Failure","OR 4.00",3.04,5.25,<0.01,Significant,"Not Adjusted",Calculated
8c250b25f233,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information","Race_ Black vs","OR 0.55",0.46,0.66,<0.01,Significant,"Not Adjusted",Calculated
b102d64ccecd,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information",Hypertension,"OR 1.84",1.61,2.09,<0.01,Significant,"Not Adjusted",Calculated
ca90197cf139,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information","Heart Disease","OR 2.57",2.11,3.14,<0.01,Significant,"Not Adjusted",Calculated
e0e8eea94b8c,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information","Chronic respiratory diseases","OR 1.19",0.98,1.44,0.08,"Not Significant","Not Adjusted",Calculated
e24071a0c26a,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information","Ethnicity_ Hispanic vs","OR 0.52",0.44,0.63,<0.01,Significant,"Not Adjusted",Calculated
e4f1e68f07d5,"Estimating Survival of Hospitalized COVID-19 Patients from Admission Information","Race_ Asian vs","OR 0.79",0.62,1.01,0.06,"Not Significant","Not Adjusted",Calculated
7e50cf6335eb,"Ethnicity and risk of death in patients hospitalised for COVID-19 infection: an observational cohort study in an urban catchment area","Race_ Black vs",AHR=1.12,0.78,1.62,0.54,"Not Significant",Adjusted,Extracted
5fa29b618bf0,"Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history","Ethnicity_ Hispanic vs",HR=0.66,0.26,1.66,0.37,"Not Significant","Not Adjusted",Extracted
71c623f2185e,"Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history",Age,HR=1.01,0.98,1.05,0.37,"Not Significant","Not Adjusted",Extracted
09a5e8043c20,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Heart Failure",AHR=1.54,1.23,1.93,<0.05,Significant,Adjusted,Extracted
0f197f360e9a,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Chronic respiratory diseases",AHR=1.03,0.83,1.29,0.76,"Not Significant",Adjusted,Extracted
11ab20282de8,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study",Cancer,AHR=1.29,1.03,1.62,<0.05,Significant,Adjusted,Extracted
34083a2cc727,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Race_ Other vs",AHR=1.17,0.86,1.6,0.31,"Not Significant",Adjusted,Extracted
3d330f7b006a,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Smoking Status",AHR=1.07,0.88,1.31,0.49,"Not Significant",Adjusted,Extracted
48aead725566,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study",Hypertension,AHR=0.98,0.78,1.23,0.86,"Not Significant",Adjusted,Extracted
48f2fbeb5329,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Race_ Asian vs",AHR=1.26,0.91,1.75,0.16,"Not Significant",Adjusted,Extracted
4f8739ff44d7,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Overweight or obese",AHR=1.01,0.82,1.25,0.94,"Not Significant",Adjusted,Extracted
5f90526f6359,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study",Diabetes,AHR=1.01,0.85,1.21,0.87,"Not Significant",Adjusted,Extracted
6dcadbb9c6d4,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Heart Disease",AHR=1.10,0.9,1.35,0.36,"Not Significant",Adjusted,Extracted
7c377298bb48,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Chronic kidney disease",AHR=0.92,0.73,1.16,0.49,"Not Significant",Adjusted,Extracted
9e3033aa1710,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Male gender",AHR=0.92,0.77,1.11,0.39,"Not Significant",Adjusted,Extracted
a553b582333b,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Overweight or obese",AHR=1.45,0.99,2.13,0.05,"Not Significant",Adjusted,Extracted
d36ab5265212,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Overweight or obese",AHR=1.08,0.87,1.36,0.48,"Not Significant",Adjusted,Extracted
e2908b7eb0ce,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Race_ Black vs",AHR=0.71,0.53,0.94,<0.05,Significant,Adjusted,Extracted
e980de45bfca,"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","Ethnicity_ Hispanic vs",AHR=1.21,0.98,1.49,0.07,"Not Significant",Adjusted,Extracted
58f6673b9f95,"Factors associated with hospitalization and critical illness among 4,103 patients with","Male gender",,,,,,,
6effc9131cc0,"Factors associated with hospitalization and critical illness among 4,103 patients with","Overweight or obese",,,,,,,
8bbe020d0145,"Factors associated with hospitalization and critical illness among 4,103 patients with",Cancer,,,,,,,
be5c024cc167,"Factors associated with hospitalization and critical illness among 4,103 patients with","Chronic kidney disease",,,,,,,
c0c4edc58663,"Factors associated with hospitalization and critical illness among 4,103 patients with","Heart Disease",,,,,,,
faa37da38908,"Factors associated with hospitalization and critical illness among 4,103 patients with","Heart Failure",,,,,,,
08d873bcb812,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19",Hypertension,,,,,,,
2def1cac9fcf,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19","Ethnicity_ Hispanic vs",,,,,,,
35df5e13f2bf,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19","Race_ Black vs",,,,,,,
44c2517dc324,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19","Chronic kidney disease",,,,,,,
6ae7e6a652ce,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19","Overweight or obese",,,,,,,
818cfb45602a,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19","Chronic respiratory diseases",,,,,,,
a0ff939a6ed9,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19","Race_ Asian vs",,,,,,,
af664786d4fe,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19",Diabetes,,,,,,,
d7ef64dd8422,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19",Cancer,,,,,,,
da5364dfa0d7,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19","Heart Disease",,,,,,,
ea6ec472056b,"Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19","Smoking Status",,,,,,,
8e3b8f0efeca,"Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol",COPD,"HR 1.19",1.05,1.34,<0.05,Significant,"Not Adjusted",Extracted
2ad361c68912,"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.","Heart Disease",HR=1.16,1.08,1.24,<0.05,Significant,Adjusted,Extracted
7d55486646a8,"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.","Overweight or obese",HR=1.33,1.19,1.49,<0.05,Significant,Adjusted,Extracted
a26937f249ce,"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.",Dementia,HR=1.40,1.28,1.52,<0.05,Significant,Adjusted,Extracted
c3ef5fe9c11e,"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.","Chronic respiratory diseases",HR=1.17,1.09,1.27,<0.05,Significant,Adjusted,Extracted
c985f465240f,"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.",Diabetes,HR=1.06,0.99,1.14,0.09,"Not Significant",Adjusted,Extracted
e5c640dfdff7,"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.","Chronic kidney disease",HR=1.28,1.18,1.39,<0.05,Significant,Adjusted,Extracted
e933520a8d32,"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.",Cancer,HR=1.13,1.02,1.24,<0.05,Significant,Adjusted,Extracted
facdf756665f,"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.","Chronic liver disease",HR=1.51,1.21,1.88,<0.05,Significant,Adjusted,Extracted
0ccb4e6a673b,"Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study",Dementia,"OR 1.54",0.55,4.32,0.41,"Not Significant","Not Adjusted",Calculated
a6bfd9673c61,"Gender-Based Disparities in COVID-19: Clinical Characteristics and Propensity-matched Analysis of Outcomes","Male gender","RR 1.44",1.24,1.67,<0.01,Significant,Adjusted,Extracted
30bc8dac075c,"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","Overweight or obese",,,,,,,
73ca23eec09c,"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","Overweight or obese",,,,,,,
b6fc57717f50,"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation",Age,,,,,,,
cb5a45d9c48f,"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation",Age,,,,,,,
cdadc9889553,"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","Overweight or obese",,,,,,,
d321d225991a,"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","Overweight or obese",,,,,,,
d365bcede9f3,"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","Overweight or obese",,,,,,,
d6d6e87262b5,"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","Overweight or obese",,,,,,,
4b91ac078b2a,"Higher mortality in men from COVID19 infection-understanding the factors that drive the differences between the biological sexes.","Male gender","OR 1.84",1.8,1.88,<0.01,Significant,"Not Adjusted",Extracted
271590793f5a,"History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study","Chronic respiratory diseases","HR 1.1",0.4,2.5,0.55,"Not Significant","Not Adjusted",Extracted
2cd0823e530e,"History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study",Age,"AHR 1.0",1.0,1.1,<0.01,"Not Significant","Not Adjusted",Calculated
3fc98431311c,"History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study","Chronic kidney disease","HR 2.3",0.9,6.0,0.09,"Not Significant","Not Adjusted",Extracted
68f04d2fc023,"History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study",COPD,"AHR 1.9",0.9,3.9,0.1,"Not Significant",Adjusted,Extracted
7b54cba37347,"History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study","Heart Failure","HR 1.9",0.9,3.9,0.1,"Not Significant","Not Adjusted",Extracted
84867d2d5de1,"History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study","Cerebrovascular disease","AHR 1.9",0.9,3.8,0.07,"Not Significant",Adjusted,Extracted
85e3941afa56,"History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study",COPD,"HR 2.6",1.2,5.6,0.01,Significant,"Not Adjusted",Extracted
d9c16d752176,"History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study","Cerebrovascular disease","HR 2.9",1.4,5.8,<0.01,Significant,"Not Adjusted",Extracted
95a4b29bd05b,"Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan","Smoking Status",,,,,,,
2ed67828235d,"Hypertension and Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19",Hypertension,"OR: 3.7",2.99,4.58,,Significant,"Not Adjusted",Extracted
343003201d97,"Hypertension and Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19",Hypertension,"AOR 1.6",1.23,1.99,,Significant,Adjusted,Extracted
0dba68e2dd8c,"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019","Heart Failure","OR 1.13",0.54,2.36,0.75,"Not Significant","Not Adjusted",Calculated
1a1fc06158cb,"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019",Diabetes,"OR 1.08",0.59,1.96,0.8,"Not Significant","Not Adjusted",Calculated
1b068811b4f3,"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019",Hypertension,"OR 1.15",0.62,2.13,0.65,"Not Significant","Not Adjusted",Calculated
339f3890c6e9,"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019","Heart Disease","OR 2.03",0.92,4.49,0.08,"Not Significant","Not Adjusted",Calculated
5a71206837ba,"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019","Race_ Black vs","OR 1.60",0.68,3.77,0.28,"Not Significant","Not Adjusted",Calculated
95a5be1a8c40,"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019",COPD,"OR 0.83",0.29,2.42,0.74,"Not Significant","Not Adjusted",Calculated
fcc93676d148,"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019","Chronic kidney disease","OR 2.68",1.39,5.17,<0.05,Significant,"Not Adjusted",Calculated
269685d08537,"ICU and ventilator mortality among critically ill adults with COVID-19","Chronic kidney disease","OR 1.82",0.92,3.61,0.09,"Not Significant","Not Adjusted",Calculated
4514a9a7a52f,"ICU and ventilator mortality among critically ill adults with COVID-19","Heart Disease","OR 2.53",1.11,5.79,0.03,Significant,"Not Adjusted",Calculated
6f80f749f343,"ICU and ventilator mortality among critically ill adults with COVID-19","Race_ Other vs","OR 0.45",0.17,1.16,0.1,"Not Significant","Not Adjusted",Calculated
702c81acc8a8,"ICU and ventilator mortality among critically ill adults with COVID-19",Hypertension,"OR 1.05",0.53,2.06,0.89,"Not Significant","Not Adjusted",Calculated
9cb37bfd6728,"ICU and ventilator mortality among critically ill adults with COVID-19",Diabetes,"OR 1.15",0.6,2.19,0.67,"Not Significant","Not Adjusted",Calculated
b769348ae1de,"ICU and ventilator mortality among critically ill adults with COVID-19","Heart Failure","OR 1.25",0.57,2.72,0.57,"Not Significant","Not Adjusted",Calculated
e1bd09d43b23,"ICU and ventilator mortality among critically ill adults with COVID-19","Race_ Black vs","OR 2.04",0.78,5.32,0.14,"Not Significant","Not Adjusted",Calculated
a6a03b60103c,"Impact of blood analysis and immune function on the prognosis of patients with COVID-19","Male gender","OR 3.18",0.82,12.4,0.09,"Not Significant","Not Adjusted",Calculated
0972ff32c0a7,"Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.",Hypertension,"OR: 3.67",2.31,5.83,,Significant,"Not Adjusted",Extracted
e348d4c09ca3,"Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.","Heart Disease","OR: 4.85",3.07,7.7,,Significant,"Not Adjusted",Extracted
825db82ed308,"Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 â€“ Systematic Review, Meta-analysis, and Meta-regression","Cerebrovascular disease","RR 2.38",1.92,2.96,<0.01,Significant,"Not Adjusted",Extracted
d227b08fcb72,"Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 â€“ Systematic Review, Meta-analysis, and Meta-regression","Heart Disease","RR 2.25",1.53,3.29,<0.01,Significant,"Not Adjusted",Extracted
39f386116dcf,"Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients","Male gender",,,,,,,
d4bf108c2508,"Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients",Hypertension,,,,,,,
fb3af693f7dc,"Incidence of venous thromboembolism in hospitalized patients with COVID-20","Male gender",,,,,,,
133229dd22c2,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis",Cancer,,,,,,,
28f92532e7d6,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis",COPD,,,,,,,
33edf7003b7f,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis","Chronic kidney disease",,,,,,,
a495ae56e6b8,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis","Smoking Status",,,,,,,
cbadfc43b6dd,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis","Cerebrovascular disease",,,,,,,
4ad5e37e2033,"Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study","Smoking Status","RR 0.81",0.44,1.48,0.49,"Not Significant","Not Adjusted",Extracted
117381319fe1,"Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.",Diabetes,,,,,,,
1e6670d2577e,"Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.",Diabetes,OR=2.95,1.93,4.53,,Significant,"Not Adjusted",Extracted
8e4f1418ff2a,"Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.",Diabetes,,,,,,,
0702c6999cdd,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Ethnicity_ Hispanic vs","RR 1.17",0.91,1.51,,"Not Significant",Adjusted,Extracted
1fe612bd26d5,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Chronic kidney disease","RR 1.33",1.1,1.61,,Significant,Adjusted,Extracted
26e83b0a4e93,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Overweight or obese","RR 1.09",0.92,1.3,,"Not Significant",Adjusted,Extracted
27e12e8789b1,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Autoimmune disorders","RR 0.87",0.66,1.16,,"Not Significant",Adjusted,Extracted
28cb37cd026e,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Neurological disorders","RR 2.10",1.72,2.56,,Significant,"Not Adjusted",Extracted
29904a27e14c,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Race_ Black vs","RR 1.07",0.85,1.35,,"Not Significant",Adjusted,Extracted
299cd24a15b6,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Immune system disorders","RR 1.39",1.13,1.7,,Significant,Adjusted,Extracted
355d64bfec57,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Heart Disease","RR 2.85",2.42,3.36,,Significant,"Not Adjusted",Extracted
373f01ca6cd1,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Smoking Status","RR 1.75",1.51,2.04,,Significant,"Not Adjusted",Extracted
3df82cf07508,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)",Hypertension,"RR 1.07",0.79,1.45,,"Not Significant",Adjusted,Extracted
4d038c0e5da2,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Chronic kidney disease","RR 2.45",2.04,2.93,,Significant,"Not Adjusted",Extracted
4d888e230228,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Race_ Black vs","RR 0.75",0.5,0.99,,Significant,"Not Adjusted",Extracted
63e2c56b2793,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)",Diabetes,"RR 1.44",1.2,1.72,,Significant,"Not Adjusted",Extracted
65c2b7ceb604,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Chronic respiratory diseases","RR 1.56",1.27,1.91,,Significant,"Not Adjusted",Extracted
6e4b1ef31520,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Immune system disorders","RR 1.58",1.33,1.88,,Significant,"Not Adjusted",Extracted
6f1c242689b1,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Heart Disease","RR 1.28",1.03,1.58,,Significant,Adjusted,Extracted
7b24da0d8523,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Overweight or obese","RR 0.73",0.61,0.86,,Significant,"Not Adjusted",Extracted
87c8f9d95577,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Smoking Status","RR 1.14",0.98,1.33,,"Not Significant",Adjusted,Extracted
9233e75cf89a,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Race_ Other vs","RR 1.26",0.86,1.82,,"Not Significant",Adjusted,Extracted
939511f41948,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Neurological disorders","RR 1.25",1.04,1.5,,Significant,Adjusted,Extracted
abb36e5811b6,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Chronic respiratory diseases","RR 1.31",1.13,1.52,,Significant,Adjusted,Extracted
b57772424da1,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)",Hypertension,"RR 2.18",1.66,2.86,,Significant,"Not Adjusted",Extracted
c0ba70ae55e1,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Autoimmune disorders","RR 1.53",1.03,2.29,,Significant,"Not Adjusted",Extracted
c2dc4dfcf7fc,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Ethnicity_ Hispanic vs","RR 0.42",0.32,0.56,,Significant,"Not Adjusted",Extracted
c5ee469b64f6,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","Race_ Other vs","RR 0.82",0.54,1.25,,"Not Significant","Not Adjusted",Extracted
e0cac441c939,"Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)",Diabetes,"RR 1.19",1.01,1.4,,Significant,Adjusted,Extracted
d7565403492e,"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis",Diabetes,"OR 1.90",1.37,2.64,,Significant,"Not Adjusted",Extracted
3d7e6619de33,"Key predictors of attending hospital with COVID19: An association study from the COVID Symptom Tracker App in 2,618,948 individuals","Male gender",,,,,,,
c83ebfa3c5f8,"Key predictors of attending hospital with COVID19: An association study from the COVID Symptom Tracker App in 2,618,948 individuals","Overweight or obese",,,,,,,
90a9ca998fe9,"Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression","Male gender",,,,,,,
b1b8fc7b1de8,"Kidney Allograft Recipients Diagnosed with Coronavirus Disease-2019: A Single Center Report","Male gender",,,,,,,
11b006e3f300,"Longitudinal association between markers of liver injury and mortality in COVIDâ€19 in China","Chronic liver disease",,,,,,,
b317193cd8da,"Longitudinal association between markers of liver injury and mortality in COVIDâ€19 in China","Male gender",,,,,,,
26bd99dad6ce,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",COPD,AHR=0.77,0.31,1.93,0.58,"Not Significant",Adjusted,Extracted
2a341f63eaa1,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",Diabetes,HR=0.64,0.45,0.93,<0.05,Significant,"Not Adjusted",Extracted
40ea9be10584,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",Age,AHR=1.02,1.01,1.03,<0.05,Significant,Adjusted,Extracted
492cf5f9b2d6,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",Hypertension,HR=0.73,0.57,0.94,<0.05,Significant,"Not Adjusted",Extracted
69a6b1b8f48a,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",Diabetes,AHR=0.57,0.35,0.92,<0.05,Significant,Adjusted,Extracted
72b33f744d6f,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19","Heart Disease",HR=1.21,0.84,1.76,0.31,"Not Significant","Not Adjusted",Extracted
83987a27dd38,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19","Heart Disease",AHR=1.11,0.71,1.71,0.66,"Not Significant",Adjusted,Extracted
87b89e55f6bb,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",Age,HR=1.02,1.01,1.03,<0.05,Significant,"Not Adjusted",Extracted
a17947c8e9cd,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",Hypertension,AHR=0.77,0.56,1.05,0.09,"Not Significant",Adjusted,Extracted
c6e67a1303d2,"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",COPD,HR=1.12,0.55,2.26,0.76,"Not Significant","Not Adjusted",Extracted
7ac5156d594f,"Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2019","Heart Disease","OR 3.27",1.63,6.45,<0.01,Significant,"Not Adjusted",Extracted
bca2c85bc13c,"Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2021","Male gender","OR 1.67",1.0,2.76,0.05,Significant,"Not Adjusted",Extracted
9e0598aabdc9,"Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2022",Hypertension,"OR 1.25",0.77,2.04,0.37,"Not Significant","Not Adjusted",Extracted
ecb0b41934eb,"Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2024",Diabetes,"OR 1.49",0.84,2.65,0.18,"Not Significant","Not Adjusted",Extracted
1f692a625c98,"Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2025","Smoking Status","OR 0.77",0.51,1.17,0.23,"Not Significant","Not Adjusted",Extracted
20371e51acf0,"Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2026","Overweight or obese","OR 2.08",0.96,4.51,0.07,"Not Significant","Not Adjusted",Extracted
dbcbdfe1af3e,"Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2026","Overweight or obese","AOR 2.55",1.03,6.33,<0.01,Significant,Adjusted,Extracted
0545808c9661,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Race_ Black vs","OR 0.87",6.88,0.09,,"Not Significant","Not Adjusted",Calculated
097822482403,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Chronic kidney disease","AOR 1.7",1.4,2.1,<0.01,Significant,Adjusted,Extracted
1f3c07eb0f68,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.",Hypertension,"AOR 0.5",0.2,1.1,0.09,"Not Significant",Adjusted,Extracted
2333d6f4afc1,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.",Diabetes,"AOR 1.4",1.2,1.7,<0.01,Significant,Adjusted,Extracted
2534ed604f03,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Overweight or obese","AOR 1.1",0.5,2.3,0.76,"Not Significant",Adjusted,Extracted
298ff7b76b0b,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Smoking Status","AOR 1.7",0.8,3.8,0.16,"Not Significant",Adjusted,Extracted
2d9d03a023ad,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.",Hypertension,"AOR 1.1",0.9,1.3,0.57,"Not Significant",Adjusted,Extracted
3b728749d009,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Heart Failure","AOR 4.0",1.6,10.4,<0.01,Significant,Adjusted,Extracted
49657a0ca0d8,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.",Cancer,"AOR 2.5",1.0,6.5,0.05,"Not Significant",Adjusted,Extracted
559de5be3cb1,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Heart Failure","AOR 1.0",0.8,1.3,0.95,"Not Significant",Adjusted,Extracted
814f668c254b,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.",Cancer,"AOR 1.0",0.8,1.2,0.94,"Not Significant",Adjusted,Extracted
92339469b93f,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Overweight or obese","AOR 1.1",0.9,1.3,0.42,"Not Significant",Adjusted,Extracted
a5fc9f2f44d0,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Race_ Black vs","OR 0.51",0.78,0.0,,Significant,"Not Adjusted",Calculated
a628a86ff749,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Race_ Other vs","OR 0.62",0.89,0.0,,Significant,"Not Adjusted",Calculated
be06d83ff142,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Race_ Other vs","OR 0.88",6.03,0.09,,"Not Significant","Not Adjusted",Calculated
c9e404df1110,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.",Diabetes,"AOR 1.3",0.7,2.6,0.44,"Not Significant",Adjusted,Extracted
d54f2e0831a3,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Heart Disease","AOR 0.6",0.2,2.1,0.42,"Not Significant",Adjusted,Extracted
dc5028daf79d,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Heart Disease","AOR 1.3",1.1,1.6,<0.01,Significant,Adjusted,Extracted
e1a36a2b0ff5,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Smoking Status","AOR 1.0",0.8,1.2,0.95,"Not Significant",Adjusted,Extracted
f08b3153a800,"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","Chronic kidney disease","AOR 3.3",1.4,7.7,<0.01,Significant,Adjusted,Extracted
72f46b9d456b,"Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients","Male gender",,,,,,,
86eda7d05f29,"Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients",Diabetes,,,,,,,
cde55e1b1284,"Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients",Hypertension,,,,,,,
5f12b324834b,"Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study",Age,"HR 1.03",0.98,1.08,0.25,"Not Significant","Not Adjusted",Extracted
63799403623c,"Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study","Cerebrovascular disease","OR 2.84",0.71,11.28,0.14,"Not Significant","Not Adjusted",Calculated
05dbc6085aab,"Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study","Cardio- and cerebrovascular disease",,,,,,,
eeb9dbb3ba16,"Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study",Cancer,,,,,,,
0f37f17cf58c,"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","Smoking Status","OR 2.93",0.72,11.94,0.13,"Not Significant","Not Adjusted",Extracted
385e34ce8558,"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19",Cancer,"OR 1.89",0.38,9.51,0.44,"Not Significant","Not Adjusted",Extracted
98f3c06010d5,"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19",COPD,"OR 4.14",0.94,18.22,0.06,"Not Significant","Not Adjusted",Extracted
ac815411bf55,"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","Heart Disease","OR 6.46",2.33,17.9,<0.05,Significant,"Not Adjusted",Extracted
d37538f9b0f6,"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","Overweight or obese","OR 1.15",1.01,1.3,<0.05,Significant,"Not Adjusted",Extracted
65637e473307,"Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage",Drinking,,,,,,,
6eb9bba41588,"No Clear Benefit to the Use of Corticosteroid as Treatment in Adult Patients with Coronavirus Disease 2019 : A Retrospective Cohort Study","Male gender",,,,,,,
fecfd8116a47,"Non-severe vs severe symptomatic COVID-19: 104 cases from the outbreak on the cruise ship Â“Diamond PrincessÂ” in Japan","Smoking Status","OR 1.49",0.52,4.23,0.46,"Not Significant","Not Adjusted",Extracted
04d738a5f4dc,"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China","Male gender",,,,,,,
398008a7aeb9,"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China","Chronic liver disease",,,,,,,
3c433df14c3a,"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China","Overweight or obese",,,,,,,
b0f0d819ab1b,"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China","Heart Disease",,,,,,,
21ebd9b2bf45,"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.",Hypertension,,,,,,,
c01b2fab7724,"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.",Diabetes,,,,,,,
c4a3ed33663a,"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.",COPD,,,,,,,
2bf7baad3974,"Obesity and COVID-19: an Italian snapshot",Age,"OR: 1.11",0.95,1.29,0.18,"Not Significant","Not Adjusted",Extracted
575ca2e1598f,"Obesity and COVID-19: an Italian snapshot",Diabetes,"OR: 2.06",0.19,22.44,0.55,"Not Significant","Not Adjusted",Extracted
634289acfad5,"Obesity and COVID-19: an Italian snapshot",Dementia,"OR: 15.81",0.9,277.43,0.06,"Not Significant","Not Adjusted",Extracted
97fe1e470c67,"Obesity and COVID-19: an Italian snapshot","Male gender","OR: 3.49",0.28,43.98,0.33,"Not Significant","Not Adjusted",Extracted
c1f4f8eb7874,"Obesity and COVID-19: an Italian snapshot","Chronic respiratory diseases","OR: 9.8",0.41,230.38,0.16,"Not Significant","Not Adjusted",Extracted
da12aa745107,"Obesity and COVID-19: an Italian snapshot","Overweight or obese","OR: 0.26",0.01,5.2,0.38,"Not Significant","Not Adjusted",Extracted
13a984731b08,"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease","Overweight or obese",,,,,,,
a92cc3ac86fd,"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease","Overweight or obese",,,,,,,
fd4dca0444d4,"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease","Overweight or obese",,,,,,,
02cedb70bf5e,"Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea","Heart Disease",,,,,,,
37a7b5cdaaf8,"Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea",Diabetes,,,,,,,
a22ac6abc6ce,"Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea","Chronic respiratory diseases",,,,,,,
c26635f4eece,"Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea",Cancer,,,,,,,
e0c60c7fad8c,"Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea",Hypertension,,,,,,,
30ef49978373,"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission","Overweight or obese",,,,,,,
fde9182e868e,"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission","Overweight or obese",,,,,,,
0f016fc78bab,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Autoimmune disorders","AHR 1.23",1.12,1.35,,Significant,Adjusted,Extracted
18a6ee06aa51,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Overweight or obese","AHR 1.27",1.18,1.36,,Significant,Adjusted,Extracted
22e80ec26a5c,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Immune system disorders","AHR 1.69",1.21,2.34,,Significant,Adjusted,Extracted
53b337b23fff,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Race_ Asian vs","AHR 1.62",1.43,1.82,,Significant,Adjusted,Extracted
594e11be1697,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Neurological disorders","AHR 2.46",2.19,2.76,,Significant,Adjusted,Extracted
6e764ee13cfd,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Race_ Other vs","AHR 1.33",1.03,1.73,,Significant,Adjusted,Extracted
9c6849506e32,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Chronic liver disease","AHR 1.61",1.33,1.95,,Significant,Adjusted,Extracted
9dc82de81bac,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Smoking Status","AHR 1.25",1.18,1.33,,Significant,Adjusted,Extracted
afbf82c34cf1,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Chronic kidney disease","AHR 1.72",1.62,1.83,,Significant,Adjusted,Extracted
bf5f67faf0b0,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.",Cancer,"AHR 1.56",1.29,1.89,,Significant,Adjusted,Extracted
d405cd73cf11,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Male gender","AHR 1.99",1.88,2.1,,Significant,Adjusted,Extracted
e099d570e2de,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Race_ Black vs","AHR 1.71",1.44,2.02,,Significant,Adjusted,Extracted
ee2cb41021f9,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.",Diabetes,"AHR 1.50",1.4,1.6,,Significant,Adjusted,Extracted
f5897a182797,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.","Heart Disease","AHR 1.27",1.2,1.35,,Significant,Adjusted,Extracted
fbca2f180f5f,"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.",Asthma,"AHR 1.25",1.08,1.44,,Significant,Adjusted,Extracted
7abc4f863148,"Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people","Race_ Black vs",HR=1.12,0.6,2.1,0.72,"Not Significant","Not Adjusted",Extracted
bcb06f026531,"Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people","Race_ Black vs",AHR=1.30,0.7,2.51,0.38,"Not Significant",Adjusted,Extracted
1615516a77b3,"Outcomes of the 2019 Novel Coronavirus in patients with or without a history of cancer - a multi-centre North London experience",Cancer,"OR 1.0",0.28,3.63,1,"Not Significant","Not Adjusted",Calculated
e005ed85fd73,"Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission",Hypertension,,,,,,,
0eee99bffc34,"Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France",Diabetes,,,,,,,
1aae3d274bfd,"Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France",Hypertension,,,,,,,
8aa6fc782949,"Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France","Heart Disease",,,,,,,
a48798e6dac6,"Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France","Overweight or obese",,,,,,,
07cf9f4fcdc4,"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study",Hypertension,"OR: 1.82",1.11,2.98,,Significant,"Not Adjusted",Extracted
1706fc943960,"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study",Cancer,"OR: 1.55",0.99,2.42,,"Not Significant","Not Adjusted",Extracted
1e0dbc02c3ad,"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study",COPD,"OR: 1.36",0.8,2.32,,"Not Significant","Not Adjusted",Extracted
7530b10ae0f1,"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","Chronic kidney disease","OR: 0.62",0.24,1.6,,"Not Significant","Not Adjusted",Extracted
e027dee484fb,"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","Chronic liver disease","OR: 0.70",0.34,1.41,,"Not Significant","Not Adjusted",Extracted
faf3ced34f56,"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","Heart Failure","OR: 2.28",1.42,3.66,,Significant,"Not Adjusted",Extracted
fd9a067dc93f,"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study",Age,"OR: 1.09",1.07,1.11,,Significant,"Not Adjusted",Extracted
34ec81c1ec19,"Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19",Hypertension,,,,,,,
431572a6647d,"Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19",Diabetes,,,,,,,
847cae529ecc,"Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19","Smoking Status",OR=3.30,1.02,10.72,<0.05,Significant,"Not Adjusted",Extracted
8b048759a2e1,"Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19","Neurological disorders",,,,,,,
acce16963b70,"Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19","Chronic digestive disorders",,,,,,,
af237eadcbf3,"Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19","Heart Disease",,,,,,,
0e602e3b008b,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity",Hypertension,,,,,,,
0ee03f3ad5ba,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Chronic respiratory diseases",,,,,,,
195ed8e8736b,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Male gender",,,,,,,
31ebcb869154,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Race_ Black vs",,,,,,,
3b59fc9f8d18,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Overweight or obese",,,,,,,
49a102fadaf7,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Ethnicity_ Hispanic vs",,,,,,,
4c86afa5dab1,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Chronic respiratory diseases",,,,,,,
50caf4372249,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity",Diabetes,,,,,,,
5f64e117e27c,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity",Diabetes,,,,,,,
69a34dd64452,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity",Hypertension,,,,,,,
bb277870c906,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Ethnicity_ Hispanic vs",,,,,,,
bfd17af45aec,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Male gender",,,,,,,
c41358c82753,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Race_ Black vs",,,,,,,
ce5de38f09a6,"Pre-Existing Characteristics Associated with Covid-19 Illness Severity","Overweight or obese",,,,,,,
7043373023ea,"Predicting COVID-19 malignant progression with AI techniques","Cardio- and cerebrovascular disease",,,,,,,
7c5b2f2b2c1c,"Predicting COVID-19 malignant progression with AI techniques","Chronic digestive disorders",,,,,,,
7bacf5a71fc3,"Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score","Smoking Status",,,,,,,
caf5a29b2c51,"Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool","Male gender","OR 0.74",0.34,1.59,0.44,"Not Significant","Not Adjusted",Calculated
fe333691831f,"Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool",Age,"AOR 1.05",1.01,1.09,0.04,Significant,Adjusted,Extracted
73a6cd6b2cda,"Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China",Diabetes,,,,,,,
8443e0983c5a,"Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China",Hypertension,,,,,,,
22c18bb54371,"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis","Heart Disease",,,,,,,
5d51bc7ba3d3,"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis",COPD,,,,,,,
6ef7400ab510,"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis",Hypertension,,,,,,,
78409d1ba3b0,"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis","Heart Disease",,,,,,,
80f781072e09,"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis",COPD,,,,,,,
8598b419d894,"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis",Hypertension,,,,,,,
f59b89650616,"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis",Diabetes,,,,,,,
f9d80f23c36d,"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis",Diabetes,,,,,,,
1461bcd2d96f,"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","Cardio- and cerebrovascular disease","OR 4.08",1.58,10.51,<0.01,Significant,"Not Adjusted",Extracted
988a1c5e88bc,"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","Cardio- and cerebrovascular disease","OR 2.46",0.76,8.04,0.01,"Not Significant",Adjusted,Extracted
4410609213f9,"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.",Hypertension,OR=2.53,2.07,3.09,<0.05,Significant,"Not Adjusted",Extracted
59e19c875b04,"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.","Cerebrovascular disease",OR=4.92,1.54,15.86,<0.05,Significant,"Not Adjusted",Extracted
adedb7f62df9,"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.",COPD,OR=2.09,0.49,8.9,0.32,"Not Significant","Not Adjusted",Extracted
af53f36114b0,"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.","Heart Disease",OR=3.81,2.11,6.85,<0.05,Significant,"Not Adjusted",Extracted
b3f18922fc32,"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.","Smoking Status",OR=1.77,0.83,3.81,0.14,"Not Significant","Not Adjusted",Extracted
c54f6f20efb7,"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.","Chronic kidney disease","OR 9.41",3.23,27.4,<0.01,Significant,"Not Adjusted",Extracted
f256764f6bba,"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.",Diabetes,OR=1.97,1.67,2.31,<0.05,Significant,"Not Adjusted",Extracted
75673d220aa9,"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep]","Chronic kidney disease",,,,,,,
80044dad1ed3,"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep]","Smoking Status",,,,,,,
9c6cd1103e3d,"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep]","Chronic respiratory diseases",,,,,,,
9e8f4e848874,"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep]","Neurological disorders",,,,,,,
dc0804e3c2b7,"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep]","Immune system disorders",,,,,,,
f756d37e07e5,"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep]","Chronic liver disease",,,,,,,
02f127b88e0c,"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","Cardio- and cerebrovascular disease",,,,,,,
6c75d7f7d3e9,"Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis",Diabetes,ES=0.44,0.27,0.62,<0.05,Significant,"Not Adjusted",Extracted
868f23ae1320,"Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis",Hypertension,ES=0.42,0.26,0.57,<0.05,Significant,"Not Adjusted",Extracted
de56105698c5,"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","Respiratory system diseases",,,,,,,
0b47e7d9cfc0,"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","Respiratory system diseases",,,,,,,
34b3e4152a80,"Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis","Smoking Status",,,,,,,
374a46d24ca4,"Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis [medrxiv]",COPD,"RR 1.1",0.6,1.8,,"Not Significant","Not Adjusted",Extracted
67637da141c1,"Prognostic value of C-reactive protein in patients with COVID-19",Age,,,,,,,
87fc26e539a6,"Prognostic value of C-reactive protein in patients with COVID-19","Chronic liver disease","OR: 1.17",0.39,3.47,0.78,"Not Significant","Not Adjusted",Calculated
9108dccc31c6,"Prognostic value of C-reactive protein in patients with COVID-19","Chronic respiratory diseases","OR: 3.74",1.57,8.89,<0.01,Significant,"Not Adjusted",Calculated
a6030226148a,"Prognostic value of C-reactive protein in patients with COVID-19","Cerebrovascular disease","OR: 3.37",1.59,7.11,<0.01,Significant,"Not Adjusted",Calculated
d2e18ef3e68d,"Prognostic value of C-reactive protein in patients with COVID-19","Smoking Status","OR: 1.63",0.65,4.08,0.3,"Not Significant","Not Adjusted",Calculated
990b3f15b885,"Prognostic value of NT-proBNP in patients with severe COVID-19",COPD,"HR 4.13 (95% CI: 0.95-18.02) p=0.06",,,,"Not Significant","Not Adjusted",Extracted
279123063c57,"Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort",COPD,"OR 2.67",0.52,13.69,0.24,"Not Significant","Not Adjusted",Extracted
71c3d780dd1d,"Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort",Hypertension,"OR 0.81",0.14,4.55,0.81,"Not Significant","Not Adjusted",Extracted
73552fb7ab53,"Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort","Chronic kidney disease","OR 5.07",0.94,27.27,0.06,"Not Significant","Not Adjusted",Extracted
74756e5551ed,"Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort","Heart Disease","OR 0.72",0.15,3.45,0.68,"Not Significant","Not Adjusted",Extracted
a704077d2632,"Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort",Dementia,"OR 5.16",1.07,24.79,0.04,Significant,"Not Adjusted",Extracted
23a1e6c3eee9,"Radiographic Findings and other Predictors in Adults with Covid-19",Age,"AOR 1.06",1.01,1.12,0.03,Significant,Adjusted,Extracted
2ab591f6e5a0,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","Cardio- and cerebrovascular disease",,,,,,,
529a3aa63efb,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","Respiratory system diseases",,,,,,,
97fe224d1aa1,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","Smoking Status",,,,,,,
9d2fd4465fe6,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","Smoking Status",,,,,,,
a09b3f11117a,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","Cardio- and cerebrovascular disease",,,,,,,
c3f64db23cb8,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","Overweight or obese",,,,,,,
fe6036bc9671,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China","Neurological disorders",,,,,,,
0d830174757e,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","Chronic respiratory diseases",OR=2.97,1.58,5.59,<0.05,Significant,"Not Adjusted",Extracted
2d8cdb0ac7bd,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","Endocrine diseases",,,,,,,
3ffeebb22ee8,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis",Hypertension,OR=2.48,1.59,3.86,<0.05,Significant,"Not Adjusted",Extracted
651c9d94778d,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis",Diabetes,OR=1.89,1.07,3.36,<0.05,Significant,"Not Adjusted",Extracted
7179c363193c,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis",COPD,OR=3.65,1.25,10.64,<0.05,Significant,"Not Adjusted",Extracted
848599f9c83e,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","Cerebrovascular disease",OR=2.98,1.4,6.35,<0.05,Significant,"Not Adjusted",Extracted
9261199edef6,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis",Cancer,,,,,,,
97934c9ffea7,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","Chronic liver disease",,,,,,,
9b4914c9d9ad,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","Chronic kidney disease",OR=4.26,0.62,29.09,0.14,"Not Significant","Not Adjusted",Extracted
ab66df5bc499,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","Heart Disease",OR=3.36,1.39,8.1,<0.05,Significant,"Not Adjusted",Extracted
b9dd5e9308e2,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","Smoking Status",OR=1.82,0.94,3.51,0.08,"Not Significant","Not Adjusted",Extracted
c3bd2957fc7d,"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","Chronic digestive disorders",OR=1.39,0.54,3.59,0.5,"Not Significant","Not Adjusted",Extracted
71e5aa7e6c60,"Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom","Race_ Asian vs",AOR=2.24,1.11,4.51,<0.05,Significant,Adjusted,Extracted
7a231ce62439,"Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom",Age,AOR=1.06,1.04,1.06,<0.05,Significant,Adjusted,Extracted
838ffe42149e,"Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom","Race_ Black vs",AOR=1.85,0.71,4.65,0.2,"Not Significant",Adjusted,Extracted
e3de55b4cca2,"Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom","Race_ Other vs",AOR=0.83,0.47,1.47,0.53,"Not Significant",Adjusted,Extracted
37a703791dcb,"Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection]","Male gender","OR 1.63",0.72,3.68,0.24,"Not Significant","Not Adjusted",Calculated
6f7fa4727cf8,"Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection]","Respiratory system diseases","OR 3.22",1.15,8.97,0.03,Significant,"Not Adjusted",Calculated
9845613eb18b,"Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection]","Heart Disease","OR 5.89",2.55,13.59,<0.01,Significant,"Not Adjusted",Calculated
9ac755d1e0e6,"Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection]","Chronic digestive disorders",,,,,,,
b1f50cf11db8,"Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection]","Endocrine diseases",,,,,,,
3c704f880272,"Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study",Age,AOR=1.12,1.01,1.25,<0.05,Significant,Adjusted,Extracted
9be8052c7d9d,"Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study",Hypertension,AOR=0.82,0.24,2.75,0.74,"Not Significant",Adjusted,Extracted
a1aff0131972,"Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study","Male gender","OR 2.97",1.76,5.01,<0.05,Significant,"Not Adjusted",Calculated
c005e63282e2,"Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study","Heart Disease","OR 1.43",0.69,2.94,0.34,"Not Significant","Not Adjusted",Calculated
ffebe1d2494c,"Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study",Diabetes,"OR 1.18",0.64,2.2,0.59,"Not Significant","Not Adjusted",Calculated
16f6e15075dd,"Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China","Male gender","OR 1.19",0.62,2.26,0.61,"Not Significant","Not Adjusted",Calculated
a3df1387ce07,"Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China",Age,"OR: 1.05",1.01,1.09,,Significant,"Not Adjusted",Extracted
243c289a6bda,"Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis","Smoking Status",,,,,,,
41b5a6b7df3b,"Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis",COPD,,,,,,,
f8eb3af054f1,"Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis",Age,,,,,,,
6e774defebea,"Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui","Heart Disease",,,,,,,
3d6a6f7a57bf,"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan","Male gender",,,,,,,
8607b7cc030f,"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan","Male gender",,,,,,,
cf0fee2bae7b,"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan","Heart Disease",,,,,,,
f7f991e41ed8,"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan",Cancer,,,,,,,
065dd0418e81,"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis",Hypertension,,,,,,,
32ec45cc6aaa,"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis","Respiratory system diseases",,,,,,,
5c52dfe2c227,"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis",Diabetes,,,,,,,
68be25642220,"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis","Chronic respiratory diseases",,,,,,,
6c271cafb483,"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis",Cancer,,,,,,,
a53ebf5d8e10,"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis","Smoking Status",,,,,,,
edac0c179db4,"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis","Heart Disease",,,,,,,
9daa693ce873,"Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Q28","Heart Disease","HR 4.28",1.14,16.13,,Significant,Adjusted,Extracted
c0a302e8d741,"Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Q28","Cerebrovascular disease","HR 3.1",1.07,8.97,,Significant,Adjusted,Extracted
5904d0f79ac7,"Risk Factors of the Severity of COVID-19: A Meta-Analysis","Smoking Status",,,,,,,
65d788996c7f,"Risk Factors of the Severity of COVID-19: A Meta-Analysis",Hypertension,,,,,,,
9c8cc6a0d092,"Risk Factors of the Severity of COVID-19: A Meta-Analysis",Diabetes,,,,,,,
f4c346ef833f,"Risk Factors of the Severity of COVID-19: A Meta-Analysis","Male gender",,,,,,,
05030a09ecbd,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.","Chronic liver disease",,,,,,,
2d375b92e570,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.","Smoking Status",,,,,,,
84bee1bbf6d5,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.",Hypertension,,,,,,,
89ce26a290d0,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.","Cardio- and cerebrovascular disease",,,,,,,
a67d4e6792f4,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.",Age,,,,,,,
ceab5fd6f816,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.","Male gender",,,,,,,
db353dcb31e7,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.",Cancer,,,,,,,
ed03407ad685,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.",Diabetes,,,,,,,
0c267b91b1f4,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Smoking Status",AOR=0.83,0.37,1.87,0.65,"Not Significant",Adjusted,Extracted
1317950b2bde,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Overweight or obese",AOR=3.94,1.56,9.92,<0.05,Significant,Adjusted,Extracted
1704468df2a0,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Chronic kidney disease",OR=2.14,1.08,4.24,<0.05,Significant,"Not Adjusted",Extracted
33b001731c57,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York",COPD,AOR=1.85,0.75,4.56,0.18,"Not Significant",Adjusted,Extracted
38f6187d4ef0,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York",Diabetes,OR=1.76,0.91,3.4,0.09,"Not Significant","Not Adjusted",Extracted
3ba1e9860072,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Heart Failure",OR=3.18,1.46,6.93,<0.05,Significant,"Not Adjusted",Extracted
4e5494b8e92d,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Heart Disease",OR=2.88,1.31,6.34,<0.05,Significant,"Not Adjusted",Extracted
52b4d420faca,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York",COPD,AOR=2.05,0.76,5.51,0.16,"Not Significant",Adjusted,Extracted
854fd3dfea16,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Overweight or obese",AOR=3.78,1.45,9.83,<0.05,Significant,Adjusted,Extracted
a39af2f843aa,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Smoking Status",OR=1.19,0.6,2.36,0.62,"Not Significant","Not Adjusted",Extracted
b810390fc3db,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Overweight or obese",OR=2.56,1.18,5.57,<0.05,Significant,"Not Adjusted",Extracted
bf69c5af4edd,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Heart Failure",AOR=1.43,0.5,4.06,0.5,"Not Significant",Adjusted,Extracted
c42b9ec01ea4,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Heart Disease",AOR=1.53,0.54,4.34,0.43,"Not Significant",Adjusted,Extracted
cc00f512593c,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Overweight or obese",AOR=3.35,1.43,7.87,<0.05,Significant,Adjusted,Extracted
d88f0c0f47f8,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York",Diabetes,AOR=1.16,0.55,2.44,0.7,"Not Significant",Adjusted,Extracted
f38f2340776b,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Heart Failure",AOR=1.46,0.52,4.13,0.47,"Not Significant",Adjusted,Extracted
fa13916bfbb8,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York",COPD,OR=3.39,1.48,7.8,<0.05,Significant,"Not Adjusted",Extracted
fc618e87ae87,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","Heart Disease",AOR=1.56,0.57,4.3,0.39,"Not Significant",Adjusted,Extracted
af3586de4f91,"Smoking is Associated with COVID-19 Progression: A Meta-Analysis","Smoking Status",,,,,,,
0f6decfd0856,"Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.",Diabetes,"OR 1.02",2.61,0.04,,Significant,"Not Adjusted",Calculated
36d50e118163,"Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.",Hypertension,"OR 0.83",1.84,0.3,,"Not Significant","Not Adjusted",Calculated
b87b0df7edf2,"Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.","Heart Disease","OR 1.33",3.91,0.0,,Significant,"Not Adjusted",Calculated
cdceac60b5f1,"Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.","Smoking Status","OR 0.63",1.87,0.78,,"Not Significant","Not Adjusted",Calculated
f43e512db87f,"Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.","Male gender","OR 1.29",2.98,0.0,,Significant,"Not Adjusted",Calculated
40dc0933b1cc,"Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection","Male gender",,,,,,,
528fe4d5ef46,"Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection",Hypertension,,,,,,,
533b91d34759,"Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection","Chronic kidney disease",,,,,,,
88f1a0ade2a6,"Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection","Heart Failure",,,,,,,
a925048fe898,"Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection",COPD,,,,,,,
b1a0ece9ad89,"Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection",Diabetes,,,,,,,
bc42092353eb,"Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection",Asthma,,,,,,,
78f9c7eb96ba,"Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China First Authors","Male gender","OR 1.52",0.66,3.52,0.33,"Not Significant","Not Adjusted",Calculated
824cbd9a2fe1,"Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China First Authors","Cardio- and cerebrovascular disease","OR 4.54",1.49,13.87,0.01,Significant,"Not Adjusted",Calculated
7da3a6fc4f5a,"Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China","Overweight or obese",,,,,,,
f50b9c6720a2,"Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.",Asthma,,,,,,,
1367fa557629,"Systematic investigations of COVID-19 in 283 cancer patients",Cancer,,,,,,,
5647d57700f4,"Systematic investigations of COVID-19 in 283 cancer patients","Smoking Status",,,,,,,
962893eec2ce,"Systematic investigations of COVID-19 in 283 cancer patients","Cerebrovascular disease",,,,,,,
a56eb76bde66,"Systematic investigations of COVID-19 in 283 cancer patients","Chronic kidney disease",,,,,,,
c29c52ae361f,"Systematic investigations of COVID-19 in 283 cancer patients",Hypertension,,,,,,,
d0ccb49378c2,"Systematic investigations of COVID-19 in 283 cancer patients",Diabetes,,,,,,,
d4dc34703a58,"Systematic investigations of COVID-19 in 283 cancer patients","Chronic liver disease",,,,,,,
d93e23ff0633,"Systematic investigations of COVID-19 in 283 cancer patients",COPD,,,,,,,
eab1974824d7,"Systematic investigations of COVID-19 in 283 cancer patients","Heart Disease",,,,,,,
19f02814d552,"Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection",COPD,,,,,,,
5187bbd8e701,"Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection",COPD,,,,,,,
006aca1f149d,"The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort","Chronic kidney disease","OR: 2.3",1.4,4.0,,Significant,"Not Adjusted",Extracted
145f70cfc986,"The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort","Heart Disease","OR: 4.5",2.5,8.0,,Significant,"Not Adjusted",Extracted
86a857316a01,"The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort",Hypertension,"OR: 2.8",1.4,5.5,,Significant,"Not Adjusted",Extracted
a4745da0270f,"The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort","Heart Disease","OR: 3.6",2.0,6.3,,Significant,"Not Adjusted",Extracted
eb567b10ed0d,"The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort","Male gender","OR: 1.4",1.0,2.2,,"Not Significant","Not Adjusted",Extracted
242dfd4cdbfd,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis","Chronic liver disease","RR 1.57",0.7,3.5,,"Not Significant","Not Adjusted",Extracted
2c0758f4403b,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis",COPD,"RR 1.76",0.92,3.36,,"Not Significant","Not Adjusted",Extracted
39efea6d25d4,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis",Cancer,"RR 1.93",1.15,3.24,,Significant,"Not Adjusted",Extracted
40bee18c252f,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis",Hypertension,"RR 1.89",1.58,2.27,,Significant,"Not Adjusted",Extracted
6fee3534c793,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis","Chronic kidney disease","RR 2.36",0.97,5.77,,"Not Significant","Not Adjusted",Extracted
700221bc580a,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis","Heart Disease","RR 2.35",1.44,3.84,,Significant,"Not Adjusted",Extracted
7b1020d4df19,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis",Diabetes,"RR 1.37",0.85,2.2,,"Not Significant","Not Adjusted",Extracted
8e0dd67adeff,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis","Heart Failure","RR 2.66",1.58,4.48,,Significant,"Not Adjusted",Extracted
fc4347ce6237,"The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis","Cerebrovascular disease","RR 2.72",0.9,8.21,,"Not Significant","Not Adjusted",Extracted
3fcfd412bf68,"The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China","Male gender","OR 0.51",5.99,0.38,,"Not Significant","Not Adjusted",Calculated
e3e63c57f324,"The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China","Heart Disease","OR 1.42",15.01,0.01,,Significant,"Not Adjusted",Calculated
fa0b4d325117,"The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China",Hypertension,"OR 0.42",6.24,0.48,,"Not Significant","Not Adjusted",Calculated
1b322bc8b438,"The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS",COPD,,,,,,,
22a7fd32c3b7,"The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS","Overweight or obese",,,,,,,
67d1a021886d,"The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS","Chronic respiratory diseases",,,,,,,
8faff124d844,"The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS","Male gender",,,,,,,
92ebd65d0282,"The Chronic Kidney Disease and Acute Kidney Injury Involvement in COVID-19 Pandemic: A Systematic Review and Meta-analysis","Chronic kidney disease",,,,,,,
6a5bb32a397c,"The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan","Smoking Status",,,,,,,
848f50526d12,"The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan","Smoking Status",,,,,,,
dae435fd1495,"The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan","Heart Disease",,,,,,,
cd1ff9d5de63,"The clinical course and its correlated immune status in COVID-19 pneumonia","Male gender",,,,,,,
d03c9c5ca2d8,"The clinical course and its correlated immune status in COVID-19 pneumonia","Endocrine diseases",,,,,,,
437713991671,"The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities","Ethnicity_ Hispanic vs","OR 0.13",0.56,0.0,,Significant,"Not Adjusted",Calculated
50cb787f5507,"The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities","Race_ Black vs","OR 0.59",1.6,0.9,,"Not Significant","Not Adjusted",Calculated
801ecd9e65fd,"The impact of COPD and smoking history on the severity of COVIDâ€19: A systemic review and metaâ€analysis",COPD,"OR: 1.93",0.59,7.43,0.11,"Not Significant","Not Adjusted",Extracted
cefe3c4d6c5d,"The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis","Smoking Status",,,,,,,
29c3edaf0777,"The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails","Heart Disease",,,,,,,
2f1c0f8b6029,"The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails",COPD,,,,,,,
47249053623b,"The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails","Cerebrovascular disease",,,,,,,
4c739debc1b2,"The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails",Hypertension,,,,,,,
67ed0debd94c,"The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails","Immune system disorders",,,,,,,
7a35a967b7cd,"The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails","Chronic liver disease",,,,,,,
9552714affdb,"The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails","Chronic kidney disease",,,,,,,
d12a7aaf7c95,"The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails",Diabetes,,,,,,,
04ae29def9b3,"The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis","Male gender",,,,,,,
47fa6bb770e1,"The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis",COPD,,,,,,,
5844a43e850a,"The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis","Male gender",,,,,,,
cf7e19d0a42b,"The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis","Heart Disease",,,,,,,
29edfdeea007,"Tobacco Induced Diseases COVID-19 and smoking: A systematic review of the evidence","Smoking Status",,,,,,,
f238a57f51ad,"Tobacco Induced Diseases COVID-19 and smoking: A systematic review of the evidence","Smoking Status",,,,,,,
0c75979372a8,"Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study","Cerebrovascular disease","AOR 2.23",2.16,2.31,,Significant,Adjusted,Extracted
2ecda69bc764,"Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study",Diabetes,"AOR 2.01",1.96,2.07,<0.01,Significant,Adjusted,Extracted
82a44926ff03,"Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study","Race_ Black vs","AOR 1.73",1.63,1.83,<0.01,Significant,Adjusted,Extracted
ce1acb0fdef5,"Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study","Race_ Other vs","AOR 1.12",1.03,1.23,0.01,Significant,Adjusted,Extracted
d5389dfedc62,"Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study","Heart Disease","AOR 1.32",1.28,1.36,,Significant,Adjusted,Extracted
f7170a539a85,"Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study","Race_ Asian vs","AOR 1.36",1.29,1.44,<0.01,Significant,Adjusted,Extracted
fed2d36e047c,"Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study","Heart Failure","AOR 2.23",2.14,2.31,,Significant,Adjusted,Extracted
e21b64f5db1a,"Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19","Chronic kidney disease",,,,,,,
38e42de44ffd,"Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-20","Heart Disease",,,,,,,
9f2c4c870c5d,"Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-21","Chronic respiratory diseases",,,,,,,
691d5f6f2199,"Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-22",Hypertension,,,,,,,
6fe835e2f100,"Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-23",Diabetes,,,,,,,
8c956a5c73a9,"Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-24","Male gender",,,,,,,
7cc85b88d401,"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy",Diabetes,,,,,,,
8ad9f687e4f1,"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy",Hypertension,,,,,,,
c3a3984ca687,"Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia","Chronic respiratory diseases",,,,,,,
3e3e883db891,"Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.","Neurological disorders",,,,,,,
502b38112d9f,"Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.","Heart Disease",,,,,,,
6719df479738,"Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.",Cancer,,,,,,,
987b79139411,"Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.","Male gender",,,,,,,
a1aa49a5163e,"Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.","Heart Disease",,,,,,,
c5a0d190815f,"Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.","Chronic kidney disease",,,,,,,
ca408c5eff4d,"Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.","Smoking Status",,,,,,,
a46b7fc4759d,"When a nephrology ward becomes a COVID-19 ward: the Cremona experience","Chronic kidney disease","OR 3.07",69.92,0.0,,Significant,"Not Adjusted",Calculated
